ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||||||||||||||||||||
17beta-estradiol
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Abcc8 | ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
multiple interactions | EXP | 1 | 96,622,574 | 96,703,723 | RGD:6480464 | CTD | |
| G | Abcc8 | ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
affects response to substance | ISO | 1 | 96,622,574 | 96,703,723 | RGD:6480464 | CTD | |
| G | Abcc8 | ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
decreases response to substance | EXP | 1 | 96,622,574 | 96,703,723 | RGD:6480464 | CTD | |
| G | Abcc8 | ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
multiple interactions | ISO | 1 | 96,622,574 | 96,703,723 | RGD:6480464 | CTD | |
| G | Abcc8 | ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
increases response to substance | EXP | 1 | 96,622,574 | 96,703,723 | RGD:6480464 | CTD | |
| G | Abcc8 | ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
affects binding | EXP | 1 | 96,622,574 | 96,703,723 | RGD:6480464 | CTD | |
| G | Abcc9 | ATP-binding cassette, subfamily C (CFTR/MRP), member 9 | affects binding | ISO | RGD:6480464 | CTD | |||||
| G | Abcc9 | ATP-binding cassette, subfamily C (CFTR/MRP), member 9 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Abhd11 | abhydrolase domain containing 11 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Adam22 | ADAM metallopeptidase domain 22 |
|
decreases expression | ISO | 4 | 22,332,086 | 22,507,086 | RGD:6480464 | CTD | |
| G | Ahr | aryl hydrocarbon receptor |
|
decreases expression | EXP | 6 | 54,205,104 | 54,240,268 | RGD:6480464 | CTD | |
| G | Alpp | alkaline phosphatase, placental |
|
increases expression | ISO | 9 | 85,885,336 | 85,888,082 | RGD:6480464 | CTD | |
| G | Alpp | alkaline phosphatase, placental |
|
multiple interactions | ISO | 9 | 85,885,336 | 85,888,082 | RGD:6480464 | CTD | |
| G | Anln | anillin, actin binding protein |
|
increases expression | ISO | 8 | 21,642,021 | 21,721,815 | RGD:6480464 | CTD | |
| G | Ap3d1 | adaptor-related protein complex 3, delta 1 subunit |
|
decreases expression | ISO | 7 | 10,480,810 | 10,516,163 | RGD:6480464 | CTD | |
| G | Aspm | asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
increases expression | ISO | 13 | 52,811,658 | 52,860,925 | RGD:6480464 | CTD | |
| G | Atad2 | ATPase family, AAA domain containing 2 |
|
increases expression | ISO | 7 | 94,808,296 | 94,851,986 | RGD:6480464 | CTD | |
| G | Atp5o | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
affects binding | EXP | 11 | 31,914,320 | 31,920,632 | RGD:6480464 | CTD | |
| G | Atp8a1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
multiple interactions | ISO | 14 | 42,923,309 | 43,165,666 | RGD:6480464 | CTD | |
| G | Atp8a1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
increases expression | ISO | 14 | 42,923,309 | 43,165,666 | RGD:6480464 | CTD | |
| G | Aurkb | aurora kinase B |
|
increases expression | ISO | 10 | 55,798,710 | 55,804,367 | RGD:6480464 | CTD | |
| G | Birc5 | baculoviral IAP repeat-containing 5 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases activity | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp8 | caspase 8 |
|
increases activity | ISO | 9 | 57,389,353 | 57,437,803 | RGD:6480464 | CTD | |
| G | Casp8 | caspase 8 |
|
multiple interactions | EXP | 9 | 57,389,353 | 57,437,803 | RGD:6480464 | CTD | |
| G | Casp9 | caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 5 | 160,704,234 | 160,721,796 | RGD:6480464 | CTD | |
| G | Casp9 | caspase 9, apoptosis-related cysteine peptidase |
|
increases activity | ISO | 5 | 160,704,234 | 160,721,796 | RGD:6480464 | CTD | |
| G | Cbx1 | chromobox homolog 1 |
|
decreases expression | ISO | 10 | 85,544,537 | 85,564,903 | RGD:6480464 | CTD | |
| G | Cbx1 | chromobox homolog 1 |
|
increases expression | ISO | 10 | 85,544,537 | 85,564,903 | RGD:6480464 | CTD | |
| G | Ccdc170 | coiled-coil domain containing 170 |
|
decreases expression | ISO | 1 | 35,196,779 | 35,290,683 | RGD:6480464 | CTD | |
| G | Ccna2 | cyclin A2 |
|
increases expression | ISO | 2 | 123,062,752 | 123,069,085 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
increases expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Cdc23 | cell division cycle 23 |
|
increases expression | EXP | 18 | 27,108,516 | 27,128,285 | RGD:6480464 | CTD | |
| G | Cdc6 | cell division cycle 6 |
|
increases expression | ISO | 10 | 87,684,493 | 87,697,865 | RGD:6480464 | CTD | |
| G | Cdca5 | cell division cycle associated 5 |
|
increases expression | ISO | 1 | 210,247,351 | 210,247,881 | RGD:6480464 | CTD | |
| G | Cdk1 | cyclin-dependent kinase 1 |
|
increases expression | ISO | 20 | 20,018,044 | 20,044,030 | RGD:6480464 | CTD | |
| G | Cdk4 | cyclin-dependent kinase 4 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cdt1 | chromatin licensing and DNA replication factor 1 |
|
increases expression | ISO | 19 | 52,848,559 | 52,853,880 | RGD:6480464 | CTD | |
| G | Cenpk | centromere protein K |
|
increases expression | ISO | 2 | 35,159,157 | 35,182,167 | RGD:6480464 | CTD | |
| G | Cfhr1 | complement factor H-related 1 |
|
affects expression | ISO | 13 | 53,135,397 | 53,150,381 | RGD:6480464 | CTD | |
| G | Cga | glycoprotein hormones, alpha polypeptide |
|
multiple interactions | EXP | 5 | 51,538,259 | 51,550,324 | RGD:6480464 | CTD | |
| G | Cga | glycoprotein hormones, alpha polypeptide |
|
decreases expression | EXP | 5 | 51,538,259 | 51,550,324 | RGD:6480464 | CTD | |
| G | Clic2 | chloride intracellular channel 2 |
|
multiple interactions | ISO | 20 | 66,518 | 81,543 | RGD:6480464 | CTD | |
| G | Clic3 | chloride intracellular channel 3 |
|
multiple interactions | ISO | 3 | 3,622,894 | 3,624,805 | RGD:6480464 | CTD | |
| G | Col6a3 | collagen, type VI, alpha 3 |
|
increases expression | ISO | 9 | 89,990,129 | 90,043,697 | RGD:6480464 | CTD | |
| G | Crispld2 | cysteine-rich secretory protein LCCL domain containing 2 |
|
multiple interactions | ISO | 19 | 50,313,710 | 50,378,031 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
increases expression | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
increases secretion | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
multiple interactions | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
multiple interactions | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
multiple interactions | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
increases expression | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp4f18 | cytochrome P450, family 4, subfamily f, polypeptide 18 |
|
decreases expression | ISO | 16 | 18,183,761 | 18,225,158 | RGD:6480464 | CTD | |
| G | Dchs1 | dachsous 1 (Drosophila) |
|
multiple interactions | ISO | 1 | 163,497,340 | 163,517,217 | RGD:6480464 | CTD | |
| G | Ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
increases expression | ISO | X | 21,498,202 | 21,505,416 | RGD:6480464 | CTD | |
| G | Dlgap5 | discs, large (Drosophila) homolog-associated protein 5 |
|
increases expression | ISO | 15 | 23,340,955 | 23,375,755 | RGD:6480464 | CTD | |
| G | E2f4 | E2F transcription factor 4, p107/p130-binding |
|
affects expression | ISO | 19 | 35,112,273 | 35,118,888 | RGD:6480464 | CTD | |
| G | Edc3 | enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 8 | 61,472,266 | 61,517,590 | RGD:6480464 | CTD | |
| G | Edc3 | enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
increases expression | ISO | 8 | 61,472,266 | 61,517,590 | RGD:6480464 | CTD | |
| G | Eif1 | eukaryotic translation initiation factor 1 |
|
affects expression | ISO | 10 | 89,255,637 | 89,257,728 | RGD:6480464 | CTD | |
| G | Eif1l1 | eukaryotic translation initiation factor 1-like 1 |
|
affects expression | ISO | 5 | 21,736,137 | 21,736,478 | RGD:6480464 | CTD | |
| G | Elovl2 | ELOVL fatty acid elongase 2 |
|
multiple interactions | ISO | 17 | 29,492,349 | 29,532,622 | RGD:6480464 | CTD | |
| G | Elovl2 | ELOVL fatty acid elongase 2 |
|
increases expression | ISO | 17 | 29,492,349 | 29,532,622 | RGD:6480464 | CTD | |
| G | Espl1 | extra spindle pole bodies homolog 1 (S. cerevisiae) |
|
increases expression | ISO | 7 | 141,048,197 | 141,074,383 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases expression | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases expression | EXP | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases expression | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
increases expression | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
increases expression | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
increases localization | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
affects binding | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
decreases expression | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
increases activity | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
increases expression | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
increases expression | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | EXP | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | EXP | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
affects binding | EXP | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
affects binding | EXP | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | EXP | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | EXP | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
decreases expression | EXP | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Ext2 | exostosin glycosyltransferase 2 |
|
affects expression | ISO | 3 | 78,111,436 | 78,244,444 | RGD:6480464 | CTD | |
| G | Fcgbp | Fc fragment of IgG binding protein |
|
increases expression | ISO | 1 | 83,177,411 | 83,215,268 | RGD:6480464 | CTD | |
| G | Fgf13 | fibroblast growth factor 13 |
|
increases expression | ISO | X | 144,199,534 | 144,533,485 | RGD:6480464 | CTD | |
| G | Fgf13 | fibroblast growth factor 13 |
|
multiple interactions | ISO | X | 144,199,534 | 144,533,485 | RGD:6480464 | CTD | |
| G | Fgf18 | fibroblast growth factor 18 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Fgf2 | fibroblast growth factor 2 |
|
increases expression | ISO | 2 | 123,893,314 | 123,947,136 | RGD:6480464 | CTD | |
| G | Fgf4 | fibroblast growth factor 4 |
|
increases expression | ISO | 1 | 205,292,272 | 205,293,705 | RGD:6480464 | CTD | |
| G | Fgf6 | fibroblast growth factor 6 |
|
increases expression | ISO | 4 | 163,403,896 | 163,412,431 | RGD:6480464 | CTD | |
| G | Fgf7 | fibroblast growth factor 7 |
|
increases expression | ISO | 3 | 113,468,427 | 113,517,538 | RGD:6480464 | CTD | |
| G | Fgf7 | fibroblast growth factor 7 |
|
increases expression | ISO | 3 | 113,468,427 | 113,517,538 | RGD:6480464 | CTD | |
| G | Fgf9 | fibroblast growth factor 9 |
|
increases expression | ISO | 15 | 37,115,068 | 37,155,652 | RGD:6480464 | CTD | |
| G | Fgf9 | fibroblast growth factor 9 |
|
increases expression | ISO | 15 | 37,115,068 | 37,155,652 | RGD:6480464 | CTD | |
| G | Fgf9 | fibroblast growth factor 9 |
|
multiple interactions | ISO | 15 | 37,115,068 | 37,155,652 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
multiple interactions | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
affects expression | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
increases expression | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
increases expression | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
decreases expression | EXP | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgfr3 | fibroblast growth factor receptor 3 |
|
increases expression | ISO | 14 | 82,683,191 | 82,697,229 | RGD:6480464 | CTD | |
| G | Fgl2 | fibrinogen-like 2 |
|
multiple interactions | ISO | 4 | 9,176,333 | 9,181,976 | RGD:6480464 | CTD | |
| G | Fhl1 | four and a half LIM domains 1 |
|
increases expression | ISO | X | 141,315,765 | 141,329,278 | RGD:6480464 | CTD | |
| G | Fhl1 | four and a half LIM domains 1 |
|
multiple interactions | ISO | X | 141,315,765 | 141,329,278 | RGD:6480464 | CTD | |
| G | Fhl1 | four and a half LIM domains 1 |
|
multiple interactions | EXP | X | 141,315,765 | 141,329,278 | RGD:6480464 | CTD | |
| G | Fhl1 | four and a half LIM domains 1 |
|
decreases expression | EXP | X | 141,315,765 | 141,329,278 | RGD:6480464 | CTD | |
| G | Fhl2 | four and a half LIM domains 2 |
|
affects expression | ISO | 9 | 42,319,997 | 42,349,055 | RGD:6480464 | CTD | |
| G | Fhl2 | four and a half LIM domains 2 |
|
multiple interactions | ISO | 9 | 42,319,997 | 42,349,055 | RGD:6480464 | CTD | |
| G | Fhl2 | four and a half LIM domains 2 |
|
multiple interactions | ISO | 9 | 42,319,997 | 42,349,055 | RGD:6480464 | CTD | |
| G | Fhl2 | four and a half LIM domains 2 |
|
increases expression | ISO | 9 | 42,319,997 | 42,349,055 | RGD:6480464 | CTD | |
| G | Ficd | FIC domain containing |
|
increases expression | ISO | 12 | 43,924,661 | 43,927,515 | RGD:6480464 | CTD | |
| G | Filip1l | filamin A interacting protein 1-like |
|
multiple interactions | ISO | 11 | 43,788,676 | 43,859,932 | RGD:6480464 | CTD | |
| G | Filip1l | filamin A interacting protein 1-like |
|
increases expression | ISO | 11 | 43,788,676 | 43,859,932 | RGD:6480464 | CTD | |
| G | Filip1l | filamin A interacting protein 1-like |
|
decreases expression | ISO | 11 | 43,788,676 | 43,859,932 | RGD:6480464 | CTD | |
| G | Fjx1 | four jointed box 1 (Drosophila) |
|
multiple interactions | ISO | 3 | 87,640,138 | 87,642,239 | RGD:6480464 | CTD | |
| G | Fkbp4 | FK506 binding protein 4 |
|
increases expression | ISO | 4 | 165,448,027 | 165,456,481 | RGD:6480464 | CTD | |
| G | Fkbp4 | FK506 binding protein 4 |
|
affects expression | ISO | 4 | 165,448,027 | 165,456,481 | RGD:6480464 | CTD | |
| G | Fkbp4 | FK506 binding protein 4 |
|
affects expression | ISO | 4 | 165,448,027 | 165,456,481 | RGD:6480464 | CTD | |
| G | Fkbp5 | FK506 binding protein 5 |
|
multiple interactions | ISO | 20 | 6,637,478 | 6,686,768 | RGD:6480464 | CTD | |
| G | Fkbpl | FK506 binding protein-like |
|
multiple interactions | ISO | 20 | 4,201,108 | 4,202,576 | RGD:6480464 | CTD | |
| G | Flna | filamin A, alpha |
|
increases expression | ISO | X | 160,362,334 | 160,385,626 | RGD:6480464 | CTD | |
| G | Flnb | filamin B, beta |
|
decreases expression | EXP | 15 | 18,949,027 | 19,082,504 | RGD:6480464 | CTD | |
| G | Flnc | filamin C, gamma |
|
decreases expression | ISO | 4 | 56,313,707 | 56,341,400 | RGD:6480464 | CTD | |
| G | Flot1 | flotillin 1 |
|
decreases expression | ISO | 20 | 3,065,792 | 3,076,166 | RGD:6480464 | CTD | |
| G | Flrt1 | fibronectin leucine rich transmembrane protein 1 |
|
affects expression | ISO | 1 | 209,764,672 | 209,770,132 | RGD:6480464 | CTD | |
| G | Flrt2 | fibronectin leucine rich transmembrane protein 2 |
|
multiple interactions | ISO | 6 | 119,569,366 | 119,658,949 | RGD:6480464 | CTD | |
| G | Flrt2 | fibronectin leucine rich transmembrane protein 2 |
|
affects expression | ISO | 6 | 119,569,366 | 119,658,949 | RGD:6480464 | CTD | |
| G | Flt1 | FMS-related tyrosine kinase 1 |
|
decreases expression | ISO | 12 | 7,858,092 | 8,035,966 | RGD:6480464 | CTD | |
| G | Fos | FBJ osteosarcoma oncogene |
|
increases expression | ISO | 6 | 109,559,135 | 109,562,001 | RGD:6480464 | CTD | |
| G | Foxc1 | forkhead box C1 |
|
increases expression | ISO | 17 | 39,026,186 | 39,030,163 | RGD:6480464 | CTD | |
| G | Foxm1 | forkhead box M1 |
|
increases expression | ISO | 4 | 165,383,666 | 165,394,688 | RGD:6480464 | CTD | |
| G | Fzd7 | frizzled family receptor 7 |
|
affects expression | ISO | 9 | 58,063,740 | 58,066,559 | RGD:6480464 | CTD | |
| G | G6pd | glucose-6-phosphate dehydrogenase |
|
multiple interactions | ISO | X | 160,186,450 | 160,192,316 | RGD:6480464 | CTD | |
| G | Gaa | glucosidase, alpha, acid | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Gabbr2 | gamma-aminobutyric acid (GABA) B receptor 2 |
|
affects expression | ISO | 5 | 63,241,397 | 63,611,907 | RGD:6480464 | CTD | |
| G | Gabbr2 | gamma-aminobutyric acid (GABA) B receptor 2 |
|
increases expression | ISO | 5 | 63,241,397 | 63,611,907 | RGD:6480464 | CTD | |
| G | Gabbr2 | gamma-aminobutyric acid (GABA) B receptor 2 |
|
multiple interactions | ISO | 5 | 63,241,397 | 63,611,907 | RGD:6480464 | CTD | |
| G | Gabpb2 | GA binding protein transcription factor, beta subunit 2 |
|
increases expression | ISO | 2 | 190,094,254 | 190,114,114 | RGD:6480464 | CTD | |
| G | Gabra3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
|
increases expression | ISO | X | 158,405,509 | 158,633,501 | RGD:6480464 | CTD | |
| G | Gabra4 | gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
|
affects expression | ISO | 14 | 39,047,461 | 39,122,531 | RGD:6480464 | CTD | |
| G | Gabra5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
|
affects expression | ISO | 1 | 108,843,086 | 108,955,130 | RGD:6480464 | CTD | |
| G | Gabrb3 | gamma-aminobutyric acid (GABA) A receptor, beta 3 |
|
increases expression | ISO | 1 | 109,047,399 | 109,277,756 | RGD:6480464 | CTD | |
| G | Gabre | gamma-aminobutyric acid (GABA) A receptor, epsilon |
|
increases expression | ISO | X | 158,335,158 | 158,353,615 | RGD:6480464 | CTD | |
| G | Gabrp | gamma-aminobutyric acid (GABA-A) receptor, pi |
|
affects expression | ISO | 10 | 18,454,555 | 18,474,564 | RGD:6480464 | CTD | |
| G | Gabrp | gamma-aminobutyric acid (GABA-A) receptor, pi |
|
increases expression | EXP | 10 | 18,454,555 | 18,474,564 | RGD:6480464 | CTD | |
| G | Gad1 | glutamate decarboxylase 1 |
|
increases expression | EXP | 3 | 52,789,370 | 52,830,038 | RGD:6480464 | CTD | |
| G | Gad2 | glutamate decarboxylase 2 |
|
increases expression | EXP | 17 | 96,259,430 | 96,321,857 | RGD:6480464 | CTD | |
| G | Gadd45a | growth arrest and DNA-damage-inducible, alpha |
|
decreases expression | ISO | 4 | 96,649,941 | 96,652,243 | RGD:6480464 | CTD | |
| G | Gadd45a | growth arrest and DNA-damage-inducible, alpha |
|
affects expression | ISO | 4 | 96,649,941 | 96,652,243 | RGD:6480464 | CTD | |
| G | Gadd45a | growth arrest and DNA-damage-inducible, alpha |
|
increases expression | ISO | 4 | 96,649,941 | 96,652,243 | RGD:6480464 | CTD | |
| G | Gadd45g | growth arrest and DNA-damage-inducible, gamma |
|
affects expression | ISO | 17 | 19,230,896 | 19,232,641 | RGD:6480464 | CTD | |
| G | Gadd45g | growth arrest and DNA-damage-inducible, gamma |
|
increases expression | ISO | 17 | 19,230,896 | 19,232,641 | RGD:6480464 | CTD | |
| G | Gal | galanin/GMAP prepropeptide |
|
multiple interactions | ISO | 1 | 205,936,352 | 205,941,215 | RGD:6480464 | CTD | |
| G | Gal | galanin/GMAP prepropeptide |
|
affects expression | ISO | 1 | 205,936,352 | 205,941,215 | RGD:6480464 | CTD | |
| G | Gal | galanin/GMAP prepropeptide |
|
increases expression | ISO | 1 | 205,936,352 | 205,941,215 | RGD:6480464 | CTD | |
| G | Gal | galanin/GMAP prepropeptide |
|
multiple interactions | EXP | 1 | 205,936,352 | 205,941,215 | RGD:6480464 | CTD | |
| G | Gal | galanin/GMAP prepropeptide |
|
multiple interactions | EXP | 1 | 205,936,352 | 205,941,215 | RGD:6480464 | CTD | |
| G | Galm | galactose mutarotase (aldose 1-epimerase) |
|
decreases expression | ISO | 6 | 3,024,123 | 3,078,720 | RGD:6480464 | CTD | |
| G | Galnt1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) |
|
affects expression | ISO | 18 | 16,013,372 | 16,052,099 | RGD:6480464 | CTD | |
| G | Galnt1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) |
|
decreases expression | EXP | 18 | 16,013,372 | 16,052,099 | RGD:6480464 | CTD | |
| G | Galnt12 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12) |
|
increases expression | ISO | 5 | 63,708,980 | 63,737,770 | RGD:6480464 | CTD | |
| G | Galnt12 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12) |
|
multiple interactions | ISO | 5 | 63,708,980 | 63,737,770 | RGD:6480464 | CTD | |
| G | Galr2 | galanin receptor 2 |
|
multiple interactions | ISO | 10 | 106,394,006 | 106,396,171 | RGD:6480464 | CTD | |
| G | Galr2 | galanin receptor 2 |
|
increases expression | ISO | 10 | 106,394,006 | 106,396,171 | RGD:6480464 | CTD | |
| G | Gap43 | growth associated protein 43 |
|
multiple interactions | ISO | 11 | 59,989,085 | 60,083,971 | RGD:6480464 | CTD | |
| G | Gars | glycyl-tRNA synthetase |
|
increases expression | ISO | 4 | 83,718,584 | 83,759,591 | RGD:6480464 | CTD | |
| G | Gas2 | growth arrest-specific 2 |
|
decreases expression | ISO | 1 | 101,697,265 | 101,798,495 | RGD:6480464 | CTD | |
| G | Gas6 | growth arrest specific 6 |
|
multiple interactions | ISO | 16 | 80,900,159 | 80,930,929 | RGD:6480464 | CTD | |
| G | Gas6 | growth arrest specific 6 |
|
increases expression | ISO | 16 | 80,900,159 | 80,930,929 | RGD:6480464 | CTD | |
| G | Gast | gastrin |
|
multiple interactions | ISO | 10 | 89,273,628 | 89,276,192 | RGD:6480464 | CTD | |
| G | Gatm | glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
decreases expression | ISO | 3 | 109,558,043 | 109,565,432 | RGD:6480464 | CTD | |
| G | Gbp1 | guanylate binding protein 1, interferon-inducible |
|
decreases expression | ISO | 2 | 240,715,506 | 240,739,741 | RGD:6480464 | CTD | |
| G | Gem | GTP binding protein overexpressed in skeletal muscle |
|
multiple interactions | ISO | 5 | 25,809,543 | 26,008,249 | RGD:6480464 | CTD | |
| G | Gem | GTP binding protein overexpressed in skeletal muscle |
|
increases expression | ISO | 5 | 25,809,543 | 26,008,249 | RGD:6480464 | CTD | |
| G | Gem | GTP binding protein overexpressed in skeletal muscle |
|
affects expression | ISO | 5 | 25,809,543 | 26,008,249 | RGD:6480464 | CTD | |
| G | Gnl3l | guanine nucleotide binding protein-like 3 (nucleolar)-like |
|
decreases expression | ISO | X | 40,301,219 | 40,334,396 | RGD:6480464 | CTD | |
| G | Golm1 | golgi membrane protein 1 |
|
multiple interactions | ISO | 17 | 10,911,513 | 10,938,960 | RGD:6480464 | CTD | |
| G | Golm1 | golgi membrane protein 1 |
|
increases expression | ISO | 17 | 10,911,513 | 10,938,960 | RGD:6480464 | CTD | |
| G | Golph2 | golgi phosphoprotein 2 |
|
increases expression | ISO | 17 | 10,870,405 | 10,876,329 | RGD:6480464 | CTD | |
| G | Gper | G protein-coupled estrogen receptor 1 |
|
multiple interactions | ISO | 12 | 15,718,615 | 15,719,893 | RGD:6480464 | CTD | |
| G | Gper | G protein-coupled estrogen receptor 1 |
|
multiple interactions | ISO | 12 | 15,718,615 | 15,719,893 | RGD:6480464 | CTD | |
| G | Gper | G protein-coupled estrogen receptor 1 |
|
multiple interactions | ISO | 12 | 15,718,615 | 15,719,893 | RGD:6480464 | CTD | |
| G | Gper | G protein-coupled estrogen receptor 1 |
|
increases activity | ISO | 12 | 15,718,615 | 15,719,893 | RGD:6480464 | CTD | |
| G | Gpnmb | glycoprotein (transmembrane) nmb |
|
decreases expression | ISO | 4 | 77,161,352 | 77,182,624 | RGD:6480464 | CTD | |
| G | Gpnmb | glycoprotein (transmembrane) nmb |
|
multiple interactions | ISO | 4 | 77,161,352 | 77,182,624 | RGD:6480464 | CTD | |
| G | Gpr116 | G protein-coupled receptor 116 |
|
increases expression | EXP | 9 | 13,217,956 | 13,323,415 | RGD:6480464 | CTD | |
| G | Gpr12 | G protein-coupled receptor 12 |
|
increases expression | EXP | 12 | 8,980,273 | 8,981,738 | RGD:6480464 | CTD | |
| G | Gpr126 | G protein-coupled receptor 126 |
|
decreases expression | ISO | 1 | 9,290,306 | 9,402,175 | RGD:6480464 | CTD | |
| G | Gpr126 | G protein-coupled receptor 126 |
|
multiple interactions | ISO | 1 | 9,290,306 | 9,402,175 | RGD:6480464 | CTD | |
| G | Gpr161 | G protein-coupled receptor 161 |
|
affects expression | ISO | 13 | 81,053,624 | 81,074,896 | RGD:6480464 | CTD | |
| G | Gpr17 | G protein-coupled receptor 17 |
|
multiple interactions | ISO | 18 | 24,374,253 | 24,375,272 | RGD:6480464 | CTD | |
| G | Gpr176 | G protein-coupled receptor 176 |
|
multiple interactions | ISO | 3 | 104,699,853 | 104,801,217 | RGD:6480464 | CTD | |
| G | Gpr176 | G protein-coupled receptor 176 |
|
affects expression | ISO | 3 | 104,699,853 | 104,801,217 | RGD:6480464 | CTD | |
| G | Gpr56 | G protein-coupled receptor 56 |
|
affects expression | ISO | 19 | 10,438,332 | 10,475,607 | RGD:6480464 | CTD | |
| G | Gpr87 | G protein-coupled receptor 87 |
|
increases expression | ISO | 2 | 148,568,437 | 148,569,597 | RGD:6480464 | CTD | |
| G | Gpr87 | G protein-coupled receptor 87 |
|
multiple interactions | ISO | 2 | 148,568,437 | 148,569,597 | RGD:6480464 | CTD | |
| G | Gprc5a | G protein-coupled receptor, family C, group 5, member A |
|
affects expression | ISO | 4 | 171,987,364 | 172,006,276 | RGD:6480464 | CTD | |
| G | Gprc5a | G protein-coupled receptor, family C, group 5, member A |
|
increases expression | ISO | 4 | 171,987,364 | 172,006,276 | RGD:6480464 | CTD | |
| G | Gprc5a | G protein-coupled receptor, family C, group 5, member A |
|
decreases expression | ISO | 4 | 171,987,364 | 172,006,276 | RGD:6480464 | CTD | |
| G | Gps2 | G protein pathway suppressor 2 |
|
multiple interactions | ISO | 10 | 56,757,674 | 56,760,194 | RGD:6480464 | CTD | |
| G | Gpt | glutamic-pyruvate transaminase (alanine aminotransferase) |
|
decreases activity | EXP | 7 | 114,746,054 | 114,748,903 | RGD:6480464 | CTD | |
| G | Gpt | glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions | EXP | 7 | 114,746,054 | 114,748,903 | RGD:6480464 | CTD | |
| G | Gpt2 | glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
decreases expression | EXP | 19 | 22,884,586 | 22,915,553 | RGD:6480464 | CTD | |
| G | Gpx2 | glutathione peroxidase 2 |
|
multiple interactions | ISO | 6 | 99,372,418 | 99,376,230 | RGD:6480464 | CTD | |
| G | Gpx2 | glutathione peroxidase 2 |
|
decreases expression | ISO | 6 | 99,372,418 | 99,376,230 | RGD:6480464 | CTD | |
| G | Gpx2 | glutathione peroxidase 2 |
|
increases expression | ISO | 6 | 99,372,418 | 99,376,230 | RGD:6480464 | CTD | |
| G | Gpx2 | glutathione peroxidase 2 |
|
multiple interactions | ISO | 6 | 99,372,418 | 99,376,230 | RGD:6480464 | CTD | |
| G | Gpx3 | glutathione peroxidase 3 |
|
multiple interactions | ISO | 10 | 40,311,094 | 40,319,382 | RGD:6480464 | CTD | |
| G | Gpx3 | glutathione peroxidase 3 |
|
increases expression | ISO | 10 | 40,311,094 | 40,319,382 | RGD:6480464 | CTD | |
| G | Gpx3 | glutathione peroxidase 3 |
|
decreases expression | ISO | 10 | 40,311,094 | 40,319,382 | RGD:6480464 | CTD | |
| G | Gramd3 | GRAM domain containing 3 |
|
decreases expression | ISO | 18 | 52,171,662 | 52,271,700 | RGD:6480464 | CTD | |
| G | Grb10 | growth factor receptor bound protein 10 |
|
affects expression | ISO | 14 | 92,814,797 | 92,911,442 | RGD:6480464 | CTD | |
| G | Grb14 | growth factor receptor bound protein 14 |
|
affects expression | ISO | 3 | 46,832,380 | 46,952,670 | RGD:6480464 | CTD | |
| G | Grb14 | growth factor receptor bound protein 14 |
|
multiple interactions | ISO | 3 | 46,832,380 | 46,952,670 | RGD:6480464 | CTD | |
| G | Grb14 | growth factor receptor bound protein 14 |
|
decreases expression | ISO | 3 | 46,832,380 | 46,952,670 | RGD:6480464 | CTD | |
| G | Grb7 | growth factor receptor bound protein 7 |
|
decreases expression | ISO | 10 | 87,252,571 | 87,261,619 | RGD:6480464 | CTD | |
| G | Grb7 | growth factor receptor bound protein 7 |
|
affects expression | ISO | 10 | 87,252,571 | 87,261,619 | RGD:6480464 | CTD | |
| G | Grin2b | glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases phosphorylation | EXP | 4 | 172,721,895 | 173,183,187 | RGD:6480464 | CTD | |
| G | Grin2b | glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions | EXP | 4 | 172,721,895 | 173,183,187 | RGD:6480464 | CTD | |
| G | Hbg1 | hemoglobin, gamma A |
|
multiple interactions | ISO | 1 | 161,640,359 | 161,641,737 | RGD:6480464 | CTD | |
| G | Hdac5 | histone deacetylase 5 |
|
affects expression | ISO | 10 | 91,266,512 | 91,277,705 | RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
increases expression | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
multiple interactions | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Hibadh | 3-hydroxyisobutyrate dehydrogenase |
|
decreases expression | EXP | 4 | 80,850,300 | 80,948,361 | RGD:6480464 | CTD | |
| G | Hif1a | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 6 | 96,419,024 | 96,463,891 | RGD:6480464 | CTD | |
| G | Hif1a | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression | EXP | 6 | 96,419,024 | 96,463,891 | RGD:6480464 | CTD | |
| G | Hira | HIR histone cell cycle regulation defective homolog A (S. cerevisiae) | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Hist1h2bd | histone cluster 1, H2bd |
|
multiple interactions | ISO | 17 | 50,429,266 | 50,429,647 | RGD:6480464 | CTD | |
| G | Hist1h2bg | histone cluster 1, H2bg |
|
multiple interactions | ISO | 17 | 48,771,873 | 48,772,253 | RGD:6480464 | CTD | |
| G | Hist1h2bh | histone cluster 1, H2bh |
|
multiple interactions | ISO | 17 | 50,111,215 | 50,111,595 | RGD:6480464 | CTD | |
| G | Hist2h2be | histone cluster 2, H2be |
|
decreases expression | ISO | 2 | 191,024,190 | 191,026,614 | RGD:6480464 | CTD | |
| G | Hk2 | hexokinase 2 |
|
decreases expression | ISO | 4 | 116,925,725 | 116,975,211 | RGD:6480464 | CTD | |
| G | Hm13 | histocompatibility 13 |
|
decreases expression | ISO | 3 | 143,020,648 | 143,059,566 | RGD:6480464 | CTD | |
| G | Hmbs | hydroxymethylbilane synthase |
|
affects expression | ISO | 8 | 47,314,235 | 47,321,604 | RGD:6480464 | CTD | |
| G | Hmgb1 | high mobility group box 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Hmgb2 | high mobility group box 2 |
|
increases expression | ISO | 16 | 36,131,304 | 36,133,878 | RGD:6480464 | CTD | |
| G | Hmgcs2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
decreases expression | ISO | 2 | 193,128,736 | 193,143,106 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
affects expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox2 | heme oxygenase (decycling) 2 |
|
affects expression | ISO | 10 | 10,914,157 | 10,929,448 | RGD:6480464 | CTD | |
| G | Hnmt | histamine N-methyltransferase |
|
multiple interactions | ISO | 3 | 2,057,938 | 2,089,955 | RGD:6480464 | CTD | |
| G | Hnmt | histamine N-methyltransferase |
|
increases expression | ISO | 3 | 2,057,938 | 2,089,955 | RGD:6480464 | CTD | |
| G | Hnrnpa2b1 | heterogeneous nuclear ribonucleoprotein A2/B1 |
|
increases expression | ISO | 4 | 79,700,327 | 79,704,116 | RGD:6480464 | CTD | |
| G | Hnrnpa2b1 | heterogeneous nuclear ribonucleoprotein A2/B1 |
|
affects expression | ISO | 4 | 79,700,327 | 79,704,116 | RGD:6480464 | CTD | |
| G | Hnrnpu | heterogeneous nuclear ribonucleoprotein U |
|
increases expression | ISO | 13 | 93,978,865 | 93,987,654 | RGD:6480464 | CTD | |
| G | Hnrpd | heterogeneous nuclear ribonucleoprotein D |
|
affects expression | ISO | 14 | 10,917,674 | 10,935,989 | RGD:6480464 | CTD | |
| G | Hnrpdl | heterogeneous nuclear ribonucleoprotein D-like |
|
affects expression | ISO | 14 | 10,861,054 | 10,864,322 | RGD:6480464 | CTD | |
| G | Homer1 | homer homolog 1 (Drosophila) | decreases expression | EXP | RGD:6480464 | CTD | |||||
| G | Hook3 | hook homolog 3 (Drosophila) |
|
decreases expression | EXP | 16 | 70,338,144 | 70,424,173 | RGD:6480464 | CTD | |
| G | Hopx | HOP homeobox |
|
multiple interactions | ISO | 14 | 33,369,052 | 33,377,948 | RGD:6480464 | CTD | |
| G | Hoxa11 | homeobox A11 |
|
increases expression | ISO | 4 | 80,542,417 | 80,546,079 | RGD:6480464 | CTD | |
| G | Hoxa11 | homeobox A11 |
|
multiple interactions | ISO | 4 | 80,542,417 | 80,546,079 | RGD:6480464 | CTD | |
| G | Hoxa11 | homeobox A11 |
|
increases expression | ISO | 4 | 80,542,417 | 80,546,079 | RGD:6480464 | CTD | |
| G | Hoxa9 | homeobox A9 |
|
multiple interactions | ISO | 4 | 80,524,246 | 80,526,491 | RGD:6480464 | CTD | |
| G | Hps5 | Hermansky-Pudlak syndrome 5 |
|
decreases expression | ISO | 1 | 97,312,474 | 97,351,792 | RGD:6480464 | CTD | |
| G | Hras | Harvey rat sarcoma virus oncogene |
|
affects expression | ISO | 1 | 201,385,705 | 201,388,987 | RGD:6480464 | CTD | |
| G | Hspb8 | heat shock protein B8 |
|
increases expression | ISO | 12 | 41,407,166 | 41,421,565 | RGD:6480464 | CTD | |
| G | Hspe1 | heat shock protein 1 (chaperonin 10) |
|
affects expression | ISO | 9 | 53,895,333 | 53,898,421 | RGD:6480464 | CTD | |
| G | Htr2c | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
affects expression | EXP | X | 31,012,921 | 31,244,127 | RGD:6480464 | CTD | |
| G | Htr2c | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
multiple interactions | EXP | X | 31,012,921 | 31,244,127 | RGD:6480464 | CTD | |
| G | Htr2c | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
increases expression | EXP | X | 31,012,921 | 31,244,127 | RGD:6480464 | CTD | |
| G | Ibsp | integrin-binding sialoprotein |
|
increases expression | ISO | 14 | 6,548,541 | 6,561,165 | RGD:6480464 | CTD | |
| G | Icam1 | intercellular adhesion molecule 1 |
|
increases expression | ISO | 8 | 20,040,177 | 20,051,939 | RGD:6480464 | CTD | |
| G | Id1 | inhibitor of DNA binding 1 |
|
multiple interactions | ISO | 3 | 143,086,162 | 143,087,289 | RGD:6480464 | CTD | |
| G | Id1 | inhibitor of DNA binding 1 |
|
increases expression | ISO | 3 | 143,086,162 | 143,087,289 | RGD:6480464 | CTD | |
| G | Id1 | inhibitor of DNA binding 1 |
|
affects expression | ISO | 3 | 143,086,162 | 143,087,289 | RGD:6480464 | CTD | |
| G | Id1 | inhibitor of DNA binding 1 |
|
multiple interactions | EXP | 3 | 143,086,162 | 143,087,289 | RGD:6480464 | CTD | |
| G | Id2 | inhibitor of DNA binding 2 |
|
decreases expression | ISO | 6 | 42,781,476 | 42,783,307 | RGD:6480464 | CTD | |
| G | Id3 | inhibitor of DNA binding 3 |
|
decreases expression | ISO | 5 | 154,934,138 | 154,935,707 | RGD:6480464 | CTD | |
| G | Ids | iduronate 2-sulfatase |
|
decreases expression | ISO | X | 156,641,266 | 156,661,031 | RGD:6480464 | CTD | |
| G | Ier2 | immediate early response 2 |
|
increases expression | ISO | 19 | 25,159,276 | 25,160,800 | RGD:6480464 | CTD | |
| G | Ier2 | immediate early response 2 |
|
affects expression | ISO | 19 | 25,159,276 | 25,160,800 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
affects expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
decreases expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
multiple interactions | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
increases expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
affects expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
increases expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ifi27 | interferon, alpha-inducible protein 27 |
|
multiple interactions | ISO | 6 | 127,725,194 | 127,731,665 | RGD:6480464 | CTD | |
| G | Ifi27 | interferon, alpha-inducible protein 27 |
|
increases expression | ISO | 6 | 127,725,194 | 127,731,665 | RGD:6480464 | CTD | |
| G | Ifi44 | interferon-induced protein 44 |
|
multiple interactions | ISO | 2 | 250,039,104 | 250,056,890 | RGD:6480464 | CTD | |
| G | Ifi44 | interferon-induced protein 44 |
|
increases expression | ISO | 2 | 250,039,104 | 250,056,890 | RGD:6480464 | CTD | |
| G | Ifi44l | interferon-induced protein 44-like | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Ifi44l | interferon-induced protein 44-like | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Ifi44l | interferon-induced protein 44-like | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Ifih1 | interferon induced with helicase C domain 1 |
|
multiple interactions | ISO | 3 | 44,547,092 | 44,593,969 | RGD:6480464 | CTD | |
| G | Ifih1 | interferon induced with helicase C domain 1 |
|
increases expression | ISO | 3 | 44,547,092 | 44,593,969 | RGD:6480464 | CTD | |
| G | Ifit1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
decreases expression | ISO | 1 | 238,609,171 | 238,611,236 | RGD:6480464 | CTD | |
| G | Ifit1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
multiple interactions | ISO | 1 | 238,609,171 | 238,611,236 | RGD:6480464 | CTD | |
| G | Ifit1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression | ISO | 1 | 238,609,171 | 238,611,236 | RGD:6480464 | CTD | |
| G | Ifit1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
affects expression | ISO | 1 | 238,609,171 | 238,611,236 | RGD:6480464 | CTD | |
| G | Ifit1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression | ISO | 1 | 238,609,171 | 238,611,236 | RGD:6480464 | CTD | |
| G | Ifit3 | interferon-induced protein with tetratricopeptide repeats 3 |
|
multiple interactions | ISO | 1 | 238,571,300 | 238,576,443 | RGD:6480464 | CTD | |
| G | Ifit3 | interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression | ISO | 1 | 238,571,300 | 238,576,443 | RGD:6480464 | CTD | |
| G | Ifit3 | interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression | ISO | 1 | 238,571,300 | 238,576,443 | RGD:6480464 | CTD | |
| G | Ifitm1 | interferon induced transmembrane protein 1 |
|
multiple interactions | ISO | 1 | 201,154,494 | 201,155,509 | RGD:6480464 | CTD | |
| G | Ifitm1 | interferon induced transmembrane protein 1 |
|
increases expression | ISO | 1 | 201,154,494 | 201,155,509 | RGD:6480464 | CTD | |
| G | Ifng | interferon gamma |
|
multiple interactions | ISO | 7 | 57,621,756 | 57,625,792 | RGD:6480464 | CTD | |
| G | Ifng | interferon gamma |
|
affects secretion | ISO | 7 | 57,621,756 | 57,625,792 | RGD:6480464 | CTD | |
| G | Ifrd1 | interferon-related developmental regulator 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Ifrd1 | interferon-related developmental regulator 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Igf1 | insulin-like growth factor 1 |
|
affects expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
increases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
increases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
multiple interactions | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
multiple interactions | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
decreases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1r | insulin-like growth factor 1 receptor |
|
increases expression | ISO | 1 | 122,704,976 | 122,990,007 | RGD:6480464 | CTD | |
| G | Igf1r | insulin-like growth factor 1 receptor |
|
multiple interactions | ISO | 1 | 122,704,976 | 122,990,007 | RGD:6480464 | CTD | |
| G | Igfbp3 | insulin-like growth factor binding protein 3 |
|
increases expression | ISO | 14 | 87,959,153 | 87,967,085 | RGD:6480464 | CTD | |
| G | Igfbp4 | insulin-like growth factor binding protein 4 |
|
increases expression | ISO | 10 | 87,822,429 | 87,834,315 | RGD:6480464 | CTD | |
| G | Igfbp5 | insulin-like growth factor binding protein 5 |
|
affects expression | ISO | 9 | 72,003,637 | 72,016,263 | RGD:6480464 | CTD | |
| G | Il17a | interleukin 17A |
|
multiple interactions | ISO | 9 | 19,454,979 | 19,458,467 | RGD:6480464 | CTD | |
| G | Il17a | interleukin 17A |
|
multiple interactions | ISO | 9 | 19,454,979 | 19,458,467 | RGD:6480464 | CTD | |
| G | Il1a | interleukin 1 alpha |
|
multiple interactions | EXP | 3 | 116,913,612 | 116,924,114 | RGD:6480464 | CTD | |
| G | Il1b | interleukin 1 beta |
|
multiple interactions | ISO | 3 | 116,964,422 | 116,970,867 | RGD:6480464 | CTD | |
| G | Il1b | interleukin 1 beta |
|
multiple interactions | EXP | 3 | 116,964,422 | 116,970,867 | RGD:6480464 | CTD | |
| G | Il2 | interleukin 2 |
|
increases secretion | ISO | 2 | 123,655,005 | 123,659,709 | RGD:6480464 | CTD | |
| G | Il20ra | interleukin 20 receptor, alpha |
|
multiple interactions | ISO | 1 | 14,965,655 | 15,009,954 | RGD:6480464 | CTD | |
| G | Il24 | interleukin 24 |
|
affects expression | ISO | 13 | 43,831,510 | 43,836,908 | RGD:6480464 | CTD | |
| G | Il24 | interleukin 24 |
|
multiple interactions | ISO | 13 | 43,831,510 | 43,836,908 | RGD:6480464 | CTD | |
| G | Il24 | interleukin 24 |
|
decreases expression | ISO | 13 | 43,831,510 | 43,836,908 | RGD:6480464 | CTD | |
| G | Il24 | interleukin 24 |
|
increases expression | ISO | 13 | 43,831,510 | 43,836,908 | RGD:6480464 | CTD | |
| G | Il24 | interleukin 24 |
|
multiple interactions | ISO | 13 | 43,831,510 | 43,836,908 | RGD:6480464 | CTD | |
| G | Il24 | interleukin 24 |
|
multiple interactions | ISO | 13 | 43,831,510 | 43,836,908 | RGD:6480464 | CTD | |
| G | Il27ra | interleukin 27 receptor, alpha |
|
multiple interactions | ISO | 19 | 25,795,355 | 25,807,317 | RGD:6480464 | CTD | |
| G | Il27ra | interleukin 27 receptor, alpha |
|
increases expression | ISO | 19 | 25,795,355 | 25,807,317 | RGD:6480464 | CTD | |
| G | Il2rb | interleukin 2 receptor, beta | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Il33 | interleukin 33 |
|
multiple interactions | ISO | 1 | 233,670,801 | 233,685,798 | RGD:6480464 | CTD | |
| G | Il4 | interleukin 4 |
|
decreases secretion | ISO | 10 | 39,074,582 | 39,080,134 | RGD:6480464 | CTD | |
| G | Il4r | interleukin 4 receptor |
|
increases expression | ISO | 1 | 184,612,903 | 184,637,863 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
increases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
increases secretion | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases secretion | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6r | interleukin 6 receptor |
|
affects expression | ISO | 2 | 182,078,049 | 182,128,135 | RGD:6480464 | CTD | |
| G | Il6st | interleukin 6 signal transducer |
|
affects expression | ISO | 2 | 43,806,301 | 43,842,365 | RGD:6480464 | CTD | |
| G | Il6st | interleukin 6 signal transducer |
|
multiple interactions | ISO | 2 | 43,806,301 | 43,842,365 | RGD:6480464 | CTD | |
| G | Il7r | interleukin 7 receptor |
|
affects expression | ISO | 2 | 59,103,992 | 59,128,004 | RGD:6480464 | CTD | |
| G | Ilf2 | interleukin enhancer binding factor 2 |
|
increases expression | ISO | 2 | 182,741,739 | 182,761,593 | RGD:6480464 | CTD | |
| G | Inha | inhibin alpha |
|
decreases expression | ISO | 9 | 74,781,223 | 74,784,124 | RGD:6480464 | CTD | |
| G | Inhba | inhibin beta-A |
|
multiple interactions | ISO | 17 | 57,244,466 | 57,257,531 | RGD:6480464 | CTD | |
| G | Inhba | inhibin beta-A |
|
decreases expression | ISO | 17 | 57,244,466 | 57,257,531 | RGD:6480464 | CTD | |
| G | Inhbb | inhibin beta-B |
|
increases expression | ISO | 13 | 32,170,987 | 32,176,689 | RGD:6480464 | CTD | |
| G | Inhbb | inhibin beta-B |
|
decreases expression | ISO | 13 | 32,170,987 | 32,176,689 | RGD:6480464 | CTD | |
| G | Inhbb | inhibin beta-B |
|
increases expression | ISO | 13 | 32,170,987 | 32,176,689 | RGD:6480464 | CTD | |
| G | Inhbe | inhibin beta E |
|
multiple interactions | ISO | 7 | 67,308,713 | 67,310,138 | RGD:6480464 | CTD | |
| G | Inhbe | inhibin beta E |
|
decreases expression | ISO | 7 | 67,308,713 | 67,310,138 | RGD:6480464 | CTD | |
| G | Inhbe | inhibin beta E |
|
increases expression | ISO | 7 | 67,308,713 | 67,310,138 | RGD:6480464 | CTD | |
| G | Inpp5k | inositol polyphosphate-5-phosphatase K |
|
decreases expression | ISO | 10 | 62,953,425 | 62,971,016 | RGD:6480464 | CTD | |
| G | Ins1 | insulin 1 |
|
decreases expression | EXP | 1 | 258,001,134 | 258,001,688 | RGD:6480464 | CTD | |
| G | Ins1 | insulin 1 |
|
increases expression | EXP | 1 | 258,001,134 | 258,001,688 | RGD:6480464 | CTD | |
| G | Ins1 | insulin 1 |
|
multiple interactions | ISO | 1 | 258,001,134 | 258,001,688 | RGD:6480464 | CTD | |
| G | Ins1 | insulin 1 |
|
multiple interactions | EXP | 1 | 258,001,134 | 258,001,688 | RGD:6480464 | CTD | |
| G | Ins2 | insulin 2 |
|
multiple interactions | ISO | 1 | 202,935,548 | 202,936,379 | RGD:6480464 | CTD | |
| G | Ins2 | insulin 2 |
|
multiple interactions | ISO | 1 | 202,935,548 | 202,936,379 | RGD:6480464 | CTD | |
| G | Insig1 | insulin induced gene 1 |
|
affects expression | ISO | 4 | 2,577,468 | 2,585,682 | RGD:6480464 | CTD | |
| G | Insr | insulin receptor |
|
decreases expression | EXP | 12 | 2,934,967 | 3,087,691 | RGD:6480464 | CTD | |
| G | Irak1 | interleukin-1 receptor-associated kinase 1 |
|
affects expression | ISO | X | 159,960,184 | 159,969,180 | RGD:6480464 | CTD | |
| G | Irs1 | insulin receptor substrate 1 |
|
increases expression | ISO | 9 | 81,585,251 | 81,638,071 | RGD:6480464 | CTD | |
| G | Irs1 | insulin receptor substrate 1 |
|
decreases expression | EXP | 9 | 81,585,251 | 81,638,071 | RGD:6480464 | CTD | |
| G | Jun | jun proto-oncogene |
|
increases expression | ISO | 5 | 115,358,166 | 115,361,259 | RGD:6480464 | CTD | |
| G | Jun | jun proto-oncogene |
|
increases expression | ISO | 5 | 115,358,166 | 115,361,259 | RGD:6480464 | CTD | |
| G | Jun | jun proto-oncogene |
|
increases expression | ISO | 5 | 115,358,166 | 115,361,259 | RGD:6480464 | CTD | |
| G | Kcnh1 | potassium voltage-gated channel, subfamily H (eag-related), member 1 |
|
increases expression | ISO | 13 | 108,129,617 | 108,407,815 | RGD:6480464 | CTD | |
| G | Kcnj16 | potassium inwardly-rectifying channel, subfamily J, member 16 |
|
decreases expression | ISO | 10 | 100,514,180 | 100,515,949 | RGD:6480464 | CTD | |
| G | Kcnj8 | potassium inwardly-rectifying channel, subfamily J, member 8 |
|
multiple interactions | ISO | 4 | 180,144,084 | 180,149,935 | RGD:6480464 | CTD | |
| G | Kcnj8 | potassium inwardly-rectifying channel, subfamily J, member 8 |
|
decreases expression | ISO | 4 | 180,144,084 | 180,149,935 | RGD:6480464 | CTD | |
| G | Kcnj8 | potassium inwardly-rectifying channel, subfamily J, member 8 |
|
multiple interactions | ISO | 4 | 180,144,084 | 180,149,935 | RGD:6480464 | CTD | |
| G | Kcnma1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
increases activity | ISO | 15 | 575,136 | 950,275 | RGD:6480464 | CTD | |
| G | Kcnma1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
multiple interactions | ISO | 15 | 575,136 | 950,275 | RGD:6480464 | CTD | |
| G | Kcnma1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
decreases expression | EXP | 15 | 575,136 | 950,275 | RGD:6480464 | CTD | |
| G | Kcnma1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
multiple interactions | EXP | 15 | 575,136 | 950,275 | RGD:6480464 | CTD | |
| G | Kcnmb1 | potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
|
increases expression | ISO | 10 | 18,904,902 | 18,912,604 | RGD:6480464 | CTD | |
| G | Kcnn4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
increases expression | ISO | 1 | 79,613,736 | 79,628,887 | RGD:6480464 | CTD | |
| G | Kcnn4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
affects expression | ISO | 1 | 79,613,736 | 79,628,887 | RGD:6480464 | CTD | |
| G | Kctd12 | potassium channel tetramerisation domain containing 12 |
|
decreases expression | ISO | 15 | 86,986,827 | 86,987,810 | RGD:6480464 | CTD | |
| G | Kdr | kinase insert domain receptor | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Kdr | kinase insert domain receptor | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Kdr | kinase insert domain receptor | increases expression | EXP | RGD:6480464 | CTD | |||||
| G | Kdr | kinase insert domain receptor | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Khk | ketohexokinase |
|
decreases expression | ISO | 6 | 25,428,263 | 25,438,497 | RGD:6480464 | CTD | |
| G | Kif11 | kinesin family member 11 |
|
increases expression | ISO | 1 | 241,668,938 | 241,722,847 | RGD:6480464 | CTD | |
| G | Kif14 | kinesin family member 14 |
|
increases expression | ISO | 13 | 49,514,095 | 49,576,012 | RGD:6480464 | CTD | |
| G | Kif15 | kinesin family member 15 |
|
increases expression | ISO | 8 | 127,694,272 | 127,764,633 | RGD:6480464 | CTD | |
| G | Kif15 | kinesin family member 15 |
|
increases expression | ISO | 8 | 127,694,272 | 127,764,633 | RGD:6480464 | CTD | |
| G | Kif20a | kinesin family member 20A |
|
increases expression | ISO | 18 | 27,100,044 | 27,108,530 | RGD:6480464 | CTD | |
| G | Kif20a | kinesin family member 20A |
|
increases expression | ISO | 18 | 27,100,044 | 27,108,530 | RGD:6480464 | CTD | |
| G | Kif23 | kinesin family member 23 |
|
increases expression | ISO | 8 | 66,050,163 | 66,077,265 | RGD:6480464 | CTD | |
| G | Kif2c | kinesin family member 2C |
|
increases expression | ISO | 5 | 137,473,698 | 137,498,974 | RGD:6480464 | CTD | |
| G | Kif3c | kinesin family member 3C |
|
decreases expression | EXP | 6 | 26,342,388 | 26,381,233 | RGD:6480464 | CTD | |
| G | Kif4a | kinesin family member 4A |
|
increases expression | ISO | X | 88,624,683 | 88,742,447 | RGD:6480464 | CTD | |
| G | Kiss1 | KiSS-1 metastasis-suppressor |
|
increases expression | ISO | 13 | 46,244,786 | 46,247,288 | RGD:6480464 | CTD | |
| G | Kiss1 | KiSS-1 metastasis-suppressor |
|
decreases expression | ISO | 13 | 46,244,786 | 46,247,288 | RGD:6480464 | CTD | |
| G | Kit | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
affects expression | ISO | 14 | 34,906,043 | 34,984,819 | RGD:6480464 | CTD | |
| G | Klf10 | Kruppel-like factor 10 |
|
multiple interactions | ISO | 7 | 73,821,190 | 73,826,866 | RGD:6480464 | CTD | |
| G | Klf10 | Kruppel-like factor 10 |
|
decreases expression | ISO | 7 | 73,821,190 | 73,826,866 | RGD:6480464 | CTD | |
| G | Klf10 | Kruppel-like factor 10 |
|
affects expression | ISO | 7 | 73,821,190 | 73,826,866 | RGD:6480464 | CTD | |
| G | Klf10 | Kruppel-like factor 10 |
|
affects expression | ISO | 7 | 73,821,190 | 73,826,866 | RGD:6480464 | CTD | |
| G | Klf4 | Kruppel-like factor 4 (gut) |
|
multiple interactions | ISO | 5 | 73,446,928 | 73,451,286 | RGD:6480464 | CTD | |
| G | Klf4 | Kruppel-like factor 4 (gut) |
|
increases expression | ISO | 5 | 73,446,928 | 73,451,286 | RGD:6480464 | CTD | |
| G | Klf6 | Kruppel-like factor 6 |
|
increases expression | ISO | 17 | 75,578,498 | 75,585,072 | RGD:6480464 | CTD | |
| G | Klk11 | kallikrein related-peptidase 11 |
|
multiple interactions | ISO | 1 | 94,204,125 | 94,208,665 | RGD:6480464 | CTD | |
| G | Klk11 | kallikrein related-peptidase 11 |
|
increases expression | ISO | 1 | 94,204,125 | 94,208,665 | RGD:6480464 | CTD | |
| G | Klk6 | kallikrein related-peptidase 6 |
|
increases expression | ISO | 1 | 94,254,350 | 94,261,500 | RGD:6480464 | CTD | |
| G | Kpna2 | karyopherin alpha 2 |
|
increases expression | ISO | 10 | 96,342,214 | 96,352,613 | RGD:6480464 | CTD | |
| G | Krt81 | keratin 81 |
|
increases expression | ISO | 7 | 140,208,280 | 140,213,180 | RGD:6480464 | CTD | |
| G | Krt81 | keratin 81 |
|
multiple interactions | ISO | 7 | 140,208,280 | 140,213,180 | RGD:6480464 | CTD | |
| G | Lgals8 | lectin, galactoside-binding, soluble, 8 |
|
multiple interactions | ISO | 17 | 68,589,595 | 68,614,014 | RGD:6480464 | CTD | |
| G | Lgals8 | lectin, galactoside-binding, soluble, 8 |
|
increases expression | ISO | 17 | 68,589,595 | 68,614,014 | RGD:6480464 | CTD | |
| G | Lgmn | legumain |
|
affects expression | ISO | 6 | 126,668,905 | 126,694,866 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
increases secretion | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
decreases expression | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
decreases secretion | ISO | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | ISO | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
decreases expression | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
decreases expression | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
decreases secretion | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
increases secretion | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Lif | leukemia inhibitory factor |
|
multiple interactions | ISO | 14 | 84,887,856 | 84,890,630 | RGD:6480464 | CTD | |
| G | Lif | leukemia inhibitory factor |
|
multiple interactions | ISO | 14 | 84,887,856 | 84,890,630 | RGD:6480464 | CTD | |
| G | Lif | leukemia inhibitory factor |
|
multiple interactions | ISO | 14 | 84,887,856 | 84,890,630 | RGD:6480464 | CTD | |
| G | Lifr | leukemia inhibitory factor receptor alpha |
|
increases expression | ISO | 2 | 56,426,058 | 56,477,198 | RGD:6480464 | CTD | |
| G | Limch1 | LIM and calponin homology domains 1 |
|
multiple interactions | ISO | 14 | 43,722,254 | 44,049,555 | RGD:6480464 | CTD | |
| G | Limch1 | LIM and calponin homology domains 1 |
|
increases expression | ISO | 14 | 43,722,254 | 44,049,555 | RGD:6480464 | CTD | |
| G | Lin7a | lin-7 homolog a (C. elegans) |
|
decreases expression | ISO | 7 | 45,970,622 | 46,116,986 | RGD:6480464 | CTD | |
| G | Lin7a | lin-7 homolog a (C. elegans) |
|
multiple interactions | ISO | 7 | 45,970,622 | 46,116,986 | RGD:6480464 | CTD | |
| G | Lin7a | lin-7 homolog a (C. elegans) |
|
decreases expression | EXP | 7 | 45,970,622 | 46,116,986 | RGD:6480464 | CTD | |
| G | Lipc | lipase, hepatic |
|
increases expression | ISO | 8 | 75,323,442 | 75,450,353 | RGD:6480464 | CTD | |
| G | Lipg | lipase, endothelial |
|
decreases expression | ISO | 18 | 71,795,150 | 71,816,056 | RGD:6480464 | CTD | |
| G | Llgl2 | lethal giant larvae homolog 2 (Drosophila) |
|
multiple interactions | ISO | 10 | 105,925,312 | 105,960,550 | RGD:6480464 | CTD | |
| G | Lmcd1 | LIM and cysteine-rich domains 1 |
|
multiple interactions | ISO | 4 | 148,071,431 | 148,130,313 | RGD:6480464 | CTD | |
| G | Lmcd1 | LIM and cysteine-rich domains 1 |
|
increases expression | ISO | 4 | 148,071,431 | 148,130,313 | RGD:6480464 | CTD | |
| G | Lmnb1 | lamin B1 |
|
decreases expression | ISO | 18 | 52,470,605 | 52,508,022 | RGD:6480464 | CTD | |
| G | LOC100359600 | karyopherin alpha 2-like |
|
increases expression | ISO | 6 | 10,523,393 | 10,524,982 | RGD:6480464 | CTD | |
| G | LOC100360205 | palladin |
|
increases expression | ISO | 16 | 31,854,459 | 31,933,792 | RGD:6480464 | CTD | |
| G | LOC100360205 | palladin |
|
affects expression | ISO | 16 | 31,854,459 | 31,933,792 | RGD:6480464 | CTD | |
| G | LOC100360929 | Ab1-108-like |
|
affects expression | ISO | 19 | 8,702,113 | 8,702,316 | RGD:6480464 | CTD | |
| G | LOC100361349 | hypothetical protein LOC100361349 |
|
affects expression | ISO | 2 | 185,155,651 | 185,161,067 | RGD:6480464 | CTD | |
| G | LOC100361349 | hypothetical protein LOC100361349 |
|
increases expression | ISO | 2 | 185,155,651 | 185,161,067 | RGD:6480464 | CTD | |
| G | LOC100362814 | hypothetical protein LOC100362814 |
|
affects expression | ISO | 3 | 89,280,382 | 89,731,855 | RGD:6480464 | CTD | |
| G | LOC100362819 | autism susceptibility candidate 2-like |
|
decreases expression | EXP | 12 | 26,069,494 | 26,166,764 | RGD:6480464 | CTD | |
| G | LOC100363014 | REST corepressor 1-like |
|
decreases expression | EXP | 6 | 135,779,610 | 135,858,591 | RGD:6480464 | CTD | |
| G | LOC686736 | similar to H3 histone, family 3B |
|
multiple interactions | ISO | 1 | 212,798,225 | 212,798,635 | RGD:6480464 | CTD | |
| G | LOC686736 | similar to H3 histone, family 3B |
|
increases expression | ISO | 1 | 212,798,225 | 212,798,635 | RGD:6480464 | CTD | |
| G | Lox | lysyl oxidase |
|
decreases expression | ISO | 18 | 47,896,674 | 47,970,829 | RGD:6480464 | CTD | |
| G | Lox | lysyl oxidase |
|
affects expression | ISO | 18 | 47,896,674 | 47,970,829 | RGD:6480464 | CTD | |
| G | Loxl1 | lysyl oxidase-like 1 |
|
multiple interactions | ISO | 8 | 62,083,052 | 62,106,827 | RGD:6480464 | CTD | |
| G | Loxl1 | lysyl oxidase-like 1 |
|
increases expression | ISO | 8 | 62,083,052 | 62,106,827 | RGD:6480464 | CTD | |
| G | Lpar1 | lysophosphatidic acid receptor 1 |
|
affects expression | ISO | 5 | 76,449,470 | 76,571,458 | RGD:6480464 | CTD | |
| G | Lpar1 | lysophosphatidic acid receptor 1 |
|
affects expression | ISO | 5 | 76,449,470 | 76,571,458 | RGD:6480464 | CTD | |
| G | Lpin1 | lipin 1 |
|
decreases expression | EXP | 6 | 40,253,664 | 40,297,195 | RGD:6480464 | CTD | |
| G | Lpl | lipoprotein lipase |
|
multiple interactions | ISO | 16 | 22,533,105 | 22,556,905 | RGD:6480464 | CTD | |
| G | Lpl | lipoprotein lipase |
|
affects expression | ISO | 16 | 22,533,105 | 22,556,905 | RGD:6480464 | CTD | |
| G | Lpl | lipoprotein lipase |
|
decreases expression | ISO | 16 | 22,533,105 | 22,556,905 | RGD:6480464 | CTD | |
| G | Lpl | lipoprotein lipase |
|
increases expression | ISO | 16 | 22,533,105 | 22,556,905 | RGD:6480464 | CTD | |
| G | Lpl | lipoprotein lipase |
|
increases expression | EXP | 16 | 22,533,105 | 22,556,905 | RGD:6480464 | CTD | |
| G | Lpo | lactoperoxidase |
|
affects expression | ISO | 10 | 76,099,137 | 76,118,724 | RGD:6480464 | CTD | |
| G | Lpo | lactoperoxidase |
|
multiple interactions | ISO | 10 | 76,099,137 | 76,118,724 | RGD:6480464 | CTD | |
| G | Lrg1 | leucine-rich alpha-2-glycoprotein 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Lrg1 | leucine-rich alpha-2-glycoprotein 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Lrp1 | low density lipoprotein receptor-related protein 1 |
|
multiple interactions | ISO | 7 | 67,520,575 | 67,601,549 | RGD:6480464 | CTD | |
| G | Lrp5 | low density lipoprotein receptor-related protein 5 |
|
multiple interactions | ISO | 1 | 206,102,750 | 206,206,350 | RGD:6480464 | CTD | |
| G | Lrrc37a | leucine rich repeat containing 37A |
|
increases expression | ISO | 10 | 92,637,325 | 92,756,555 | RGD:6480464 | CTD | |
| G | Ltf | lactotransferrin |
|
increases expression | ISO | 8 | 115,417,764 | 115,440,609 | RGD:6480464 | CTD | |
| G | Ltf | lactotransferrin |
|
multiple interactions | ISO | 8 | 115,417,764 | 115,440,609 | RGD:6480464 | CTD | |
| G | Map3k5 | mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions | ISO | 1 | 15,205,361 | 15,346,422 | RGD:6480464 | CTD | |
| G | Map3k5 | mitogen-activated protein kinase kinase kinase 5 |
|
increases expression | ISO | 1 | 15,205,361 | 15,346,422 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
decreases phosphorylation | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
affects phosphorylation | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases activity | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk14 | mitogen activated protein kinase 14 |
|
increases activity | ISO | 20 | 6,939,249 | 7,000,378 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
affects phosphorylation | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases activity | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
decreases expression | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
decreases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
affects expression | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
decreases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk8 | mitogen-activated protein kinase 8 |
|
decreases expression | ISO | 16 | 8,925,133 | 9,004,897 | RGD:6480464 | CTD | |
| G | Mapk8 | mitogen-activated protein kinase 8 |
|
multiple interactions | EXP | 16 | 8,925,133 | 9,004,897 | RGD:6480464 | CTD | |
| G | Mapkapk2 | mitogen-activated protein kinase-activated protein kinase 2 |
|
affects expression | ISO | 13 | 43,994,943 | 44,041,504 | RGD:6480464 | CTD | |
| G | Mapre1 | microtubule-associated protein, RP/EB family, member 1 |
|
increases expression | ISO | 3 | 144,120,532 | 144,148,856 | RGD:6480464 | CTD | |
| G | Mapt | microtubule-associated protein tau |
|
multiple interactions | ISO | 10 | 93,411,098 | 93,508,762 | RGD:6480464 | CTD | |
| G | Mapt | microtubule-associated protein tau |
|
increases expression | ISO | 10 | 93,411,098 | 93,508,762 | RGD:6480464 | CTD | |
| G | Marcks | myristoylated alanine rich protein kinase C substrate |
|
multiple interactions | ISO | 20 | 41,304,058 | 41,310,104 | RGD:6480464 | CTD | |
| G | Marcks | myristoylated alanine rich protein kinase C substrate |
|
increases expression | EXP | 20 | 41,304,058 | 41,310,104 | RGD:6480464 | CTD | |
| G | Maz | MYC-associated zinc finger protein (purine-binding transcription factor) |
|
affects expression | ISO | 1 | 186,201,083 | 186,204,364 | RGD:6480464 | CTD | |
| G | Mcm10 | minichromosome maintenance complex component 10 |
|
increases expression | ISO | 17 | 84,354,481 | 84,375,749 | RGD:6480464 | CTD | |
| G | Mcm3 | minichromosome maintenance complex component 3 |
|
increases expression | ISO | 9 | 19,536,922 | 19,554,871 | RGD:6480464 | CTD | |
| G | Med6 | mediator complex subunit 6 |
|
affects expression | ISO | 6 | 105,432,911 | 105,446,531 | RGD:6480464 | CTD | |
| G | Mef2a | myocyte enhancer factor 2a | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Mfsd10 | major facilitator superfamily domain containing 10 |
|
affects expression | ISO | 14 | 81,745,997 | 81,748,824 | RGD:6480464 | CTD | |
| G | Mgp | matrix Gla protein |
|
increases expression | ISO | 4 | 173,910,595 | 173,913,917 | RGD:6480464 | CTD | |
| G | Micall1 | MICAL-like 1 |
|
increases expression | ISO | 7 | 117,087,550 | 117,113,280 | RGD:6480464 | CTD | |
| G | Mki67 | antigen identified by monoclonal antibody Ki-67 |
|
increases expression | ISO | 1 | 195,310,027 | 195,336,224 | RGD:6480464 | CTD | |
| G | Mki67 | antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions | ISO | 1 | 195,310,027 | 195,336,224 | RGD:6480464 | CTD | |
| G | Mki67 | antigen identified by monoclonal antibody Ki-67 |
|
increases expression | ISO | 1 | 195,310,027 | 195,336,224 | RGD:6480464 | CTD | |
| G | Mlf1ip | MLF1 interacting protein |
|
increases expression | ISO | 16 | 48,997,465 | 49,020,684 | RGD:6480464 | CTD | |
| G | Mll5 | myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog, Drosophila) |
|
decreases expression | EXP | 4 | 7,042,012 | 7,111,851 | RGD:6480464 | CTD | |
| G | Mme | membrane metallo-endopeptidase |
|
decreases expression | ISO | 2 | 153,031,724 | 153,114,515 | RGD:6480464 | CTD | |
| G | Mmp1 | matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions | ISO | 8 | 4,333,773 | 4,354,284 | RGD:6480464 | CTD | |
| G | Mmp1 | matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions | ISO | 8 | 4,333,773 | 4,354,284 | RGD:6480464 | CTD | |
| G | Mmp10 | matrix metallopeptidase 10 (stromelysin 2) |
|
increases expression | ISO | 8 | 4,367,842 | 4,375,737 | RGD:6480464 | CTD | |
| G | Mmp11 | matrix metallopeptidase 11 |
|
multiple interactions | ISO | 20 | 13,129,667 | 13,138,449 | RGD:6480464 | CTD | |
| G | Mmp12 | matrix metallopeptidase 12 |
|
multiple interactions | ISO | 8 | 4,249,938 | 4,259,675 | RGD:6480464 | CTD | |
| G | Mmp12 | matrix metallopeptidase 12 |
|
affects expression | ISO | 8 | 4,249,938 | 4,259,675 | RGD:6480464 | CTD | |
| G | Mmp14 | matrix metallopeptidase 14 (membrane-inserted) |
|
multiple interactions | ISO | 15 | 32,493,852 | 32,503,077 | RGD:6480464 | CTD | |
| G | Mmp15 | matrix metallopeptidase 15 |
|
decreases expression | ISO | 19 | 10,122,553 | 10,143,853 | RGD:6480464 | CTD | |
| G | Mmp2 | matrix metallopeptidase 2 |
|
increases activity | ISO | 19 | 15,246,036 | 15,275,061 | RGD:6480464 | CTD | |
| G | Mmp27 | matrix metallopeptidase 27 |
|
multiple interactions | ISO | 8 | 4,423,907 | 4,433,826 | RGD:6480464 | CTD | |
| G | Mmp3 | matrix metallopeptidase 3 |
|
increases expression | ISO | 8 | 4,315,601 | 4,329,146 | RGD:6480464 | CTD | |
| G | Mmp3 | matrix metallopeptidase 3 |
|
increases secretion | ISO | 8 | 4,315,601 | 4,329,146 | RGD:6480464 | CTD | |
| G | Mmp3 | matrix metallopeptidase 3 |
|
multiple interactions | ISO | 8 | 4,315,601 | 4,329,146 | RGD:6480464 | CTD | |
| G | Mmp3 | matrix metallopeptidase 3 |
|
multiple interactions | ISO | 8 | 4,315,601 | 4,329,146 | RGD:6480464 | CTD | |
| G | Mmp7 | matrix metallopeptidase 7 |
|
multiple interactions | ISO | 8 | 4,526,018 | 4,533,730 | RGD:6480464 | CTD | |
| G | Mmp7 | matrix metallopeptidase 7 |
|
increases secretion | ISO | 8 | 4,526,018 | 4,533,730 | RGD:6480464 | CTD | |
| G | Mmp7 | matrix metallopeptidase 7 |
|
increases expression | ISO | 8 | 4,526,018 | 4,533,730 | RGD:6480464 | CTD | |
| G | Mmp7 | matrix metallopeptidase 7 |
|
multiple interactions | EXP | 8 | 4,526,018 | 4,533,730 | RGD:6480464 | CTD | |
| G | Mmp9 | matrix metallopeptidase 9 |
|
multiple interactions | ISO | 3 | 155,985,473 | 155,993,433 | RGD:6480464 | CTD | |
| G | Mmp9 | matrix metallopeptidase 9 |
|
increases activity | ISO | 3 | 155,985,473 | 155,993,433 | RGD:6480464 | CTD | |
| G | Mmp9 | matrix metallopeptidase 9 |
|
increases expression | ISO | 3 | 155,985,473 | 155,993,433 | RGD:6480464 | CTD | |
| G | Mnd1 | meiotic nuclear divisions 1 homolog (S. cerevisiae) |
|
increases expression | ISO | 2 | 175,841,810 | 175,906,450 | RGD:6480464 | CTD | |
| G | Mns1 | meiosis-specific nuclear structural 1 |
|
increases expression | ISO | 8 | 77,015,290 | 77,035,979 | RGD:6480464 | CTD | |
| G | Mobp | myelin-associated oligodendrocyte basic protein |
|
increases expression | EXP | 8 | 125,118,618 | 125,144,099 | RGD:6480464 | CTD | |
| G | Mogat1 | monoacylglycerol O-acyltransferase 1 |
|
decreases expression | ISO | 9 | 77,901,139 | 77,908,689 | RGD:6480464 | CTD | |
| G | Mok | MOK protein kinase |
|
increases expression | ISO | 6 | 135,531,656 | 135,562,497 | RGD:6480464 | CTD | |
| G | Mphosph9 | M-phase phosphoprotein 9 |
|
increases expression | ISO | 12 | 33,394,159 | 33,457,830 | RGD:6480464 | CTD | |
| G | Mpped2 | metallophosphoesterase domain containing 2 |
|
multiple interactions | ISO | 3 | 92,197,073 | 92,370,714 | RGD:6480464 | CTD | |
| G | Mpped2 | metallophosphoesterase domain containing 2 |
|
increases expression | ISO | 3 | 92,197,073 | 92,370,714 | RGD:6480464 | CTD | |
| G | mrpl11 | mitochondrial ribosomal protein L11 |
|
affects expression | ISO | 1 | 207,580,240 | 207,583,065 | RGD:6480464 | CTD | |
| G | Mrpl12 | mitochondrial ribosomal protein L12 |
|
affects expression | ISO | 10 | 109,870,160 | 109,874,664 | RGD:6480464 | CTD | |
| G | Mrpl18 | mitochondrial ribosomal protein L18 |
|
increases expression | ISO | 1 | 42,111,647 | 42,116,465 | RGD:6480464 | CTD | |
| G | Mrpl20 | mitochondrial ribosomal protein L20 |
|
affects expression | ISO | 5 | 172,657,923 | 172,662,453 | RGD:6480464 | CTD | |
| G | Mrpl52 | mitochondrial ribosomal protein L52 |
|
affects expression | ISO | 15 | 32,488,908 | 32,491,857 | RGD:6480464 | CTD | |
| G | Mrps18b | mitochondrial ribosomal protein S18B |
|
affects expression | ISO | 20 | 2,985,972 | 2,992,031 | RGD:6480464 | CTD | |
| G | Msmb | microseminoprotein, beta |
|
increases expression | EXP | 16 | 7,619,432 | 7,640,019 | RGD:6480464 | CTD | |
| G | Mst1 | Macrophage stimulating 1 (hepatocyte growth factor-like) |
|
increases expression | ISO | 8 | 113,348,203 | 113,352,773 | RGD:6480464 | CTD | |
| G | Mst4 | serine/threonine protein kinase MST4 |
|
increases expression | ISO | X | 137,577,961 | 137,627,511 | RGD:6480464 | CTD | |
| G | Mt1a | metallothionein 1a |
|
increases expression | ISO | 19 | 11,261,631 | 11,262,647 | RGD:6480464 | CTD | |
| G | Mt2A | metallothionein 2A |
|
increases expression | ISO | 19 | 11,267,811 | 11,268,585 | RGD:6480464 | CTD | |
| G | Mt2A | metallothionein 2A |
|
multiple interactions | ISO | 19 | 11,267,811 | 11,268,585 | RGD:6480464 | CTD | |
| G | Mt2A | metallothionein 2A |
|
increases expression | ISO | 19 | 11,267,811 | 11,268,585 | RGD:6480464 | CTD | |
| G | Mt2A | metallothionein 2A |
|
multiple interactions | ISO | 19 | 11,267,811 | 11,268,585 | RGD:6480464 | CTD | |
| G | Mta3 | metastasis associated 1 family, member 3 |
|
increases expression | ISO | 6 6 |
7,060,212 7,060,212 |
7,180,405 7,180,405 |
RGD:6480464 | CTD | |
| G | Mthfd1 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase |
|
decreases expression | ISO | 6 | 98,849,446 | 98,916,936 | RGD:6480464 | CTD | |
| G | Mthfd1l | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
|
increases expression | ISO | 1 | 34,759,445 | 34,800,865 | RGD:6480464 | CTD | |
| G | Mtor | mechanistic target of rapamycin (serine/threonine kinase) |
|
increases activity | ISO | 5 | 165,531,402 | 165,640,899 | RGD:6480464 | CTD | |
| G | Mtor | mechanistic target of rapamycin (serine/threonine kinase) |
|
affects activity | ISO | 5 | 165,531,402 | 165,640,899 | RGD:6480464 | CTD | |
| G | Mtor | mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions | ISO | 5 | 165,531,402 | 165,640,899 | RGD:6480464 | CTD | |
| G | Mybl1 | myeloblastosis oncogene-like 1 |
|
increases expression | ISO | 5 | 9,136,980 | 9,170,799 | RGD:6480464 | CTD | |
| G | Mybl1 | myeloblastosis oncogene-like 1 |
|
increases expression | ISO | 5 | 9,136,980 | 9,170,799 | RGD:6480464 | CTD | |
| G | Mybl2 | myeloblastosis oncogene-like 2 |
|
increases expression | ISO | 3 | 153,925,908 | 153,954,323 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
multiple interactions | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
multiple interactions | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
affects expression | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
increases expression | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
multiple interactions | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Nav2 | neuron navigator 2 |
|
multiple interactions | ISO | 1 | 99,041,044 | 99,410,077 | RGD:6480464 | CTD | |
| G | Nav2 | neuron navigator 2 |
|
increases expression | ISO | 1 | 99,041,044 | 99,410,077 | RGD:6480464 | CTD | |
| G | Ncoa1 | nuclear receptor coactivator 1 |
|
decreases expression | ISO | 6 | 27,224,396 | 27,473,926 | RGD:6480464 | CTD | |
| G | Ncoa1 | nuclear receptor coactivator 1 |
|
increases expression | ISO | 6 | 27,224,396 | 27,473,926 | RGD:6480464 | CTD | |
| G | Ncoa1 | nuclear receptor coactivator 1 |
|
multiple interactions | ISO | 6 | 27,224,396 | 27,473,926 | RGD:6480464 | CTD | |
| G | Ncoa1 | nuclear receptor coactivator 1 |
|
affects localization | ISO | 6 | 27,224,396 | 27,473,926 | RGD:6480464 | CTD | |
| G | Ncoa1 | nuclear receptor coactivator 1 |
|
multiple interactions | EXP | 6 | 27,224,396 | 27,473,926 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
multiple interactions | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
affects binding | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
multiple interactions | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
multiple interactions | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
multiple interactions | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
multiple interactions | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
multiple interactions | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
increases expression | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
multiple interactions | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
affects localization | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
decreases expression | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
increases phosphorylation | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
decreases expression | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
increases expression | EXP | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncor1 | nuclear receptor co-repressor 1 |
|
multiple interactions | ISO | 10 | 48,481,110 | 48,628,538 | RGD:6480464 | CTD | |
| G | Ncor1 | nuclear receptor co-repressor 1 |
|
multiple interactions | ISO | 10 | 48,481,110 | 48,628,538 | RGD:6480464 | CTD | |
| G | Ncor1 | nuclear receptor co-repressor 1 |
|
multiple interactions | ISO | 10 | 48,481,110 | 48,628,538 | RGD:6480464 | CTD | |
| G | Ncor1 | nuclear receptor co-repressor 1 |
|
multiple interactions | ISO | 10 | 48,481,110 | 48,628,538 | RGD:6480464 | CTD | |
| G | Ncor1 | nuclear receptor co-repressor 1 |
|
multiple interactions | EXP | 10 | 48,481,110 | 48,628,538 | RGD:6480464 | CTD | |
| G | Ncor2 | nuclear receptor co-repressor 2 |
|
multiple interactions | ISO | 12 | 32,617,643 | 32,725,753 | RGD:6480464 | CTD | |
| G | Ncor2 | nuclear receptor co-repressor 2 |
|
decreases expression | ISO | 12 | 32,617,643 | 32,725,753 | RGD:6480464 | CTD | |
| G | Ncor2 | nuclear receptor co-repressor 2 |
|
increases expression | ISO | 12 | 32,617,643 | 32,725,753 | RGD:6480464 | CTD | |
| G | Ncor2 | nuclear receptor co-repressor 2 |
|
multiple interactions | ISO | 12 | 32,617,643 | 32,725,753 | RGD:6480464 | CTD | |
| G | Ncor2 | nuclear receptor co-repressor 2 |
|
affects expression | ISO | 12 | 32,617,643 | 32,725,753 | RGD:6480464 | CTD | |
| G | Ndc80 | NDC80 kinetochore complex component |
|
increases expression | ISO | 9 | 110,702,935 | 110,718,894 | RGD:6480464 | CTD | |
| G | Ndp | Norrie disease (pseudoglioma) |
|
multiple interactions | ISO | X | 17,416,946 | 17,441,393 | RGD:6480464 | CTD | |
| G | Ndrg1 | N-myc downstream regulated 1 |
|
multiple interactions | ISO | 7 | 104,302,038 | 104,344,842 | RGD:6480464 | CTD | |
| G | Ndrg1 | N-myc downstream regulated 1 |
|
increases expression | ISO | 7 | 104,302,038 | 104,344,842 | RGD:6480464 | CTD | |
| G | Ndrg2 | NDRG family member 2 |
|
decreases expression | ISO | 15 | 27,338,552 | 27,347,196 | RGD:6480464 | CTD | |
| G | Ndufb4 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 |
|
decreases expression | ISO | 11 | 64,852,589 | 64,859,550 | RGD:6480464 | CTD | |
| G | Neb | nebulin |
|
decreases expression | ISO | 3 | 33,634,963 | 33,833,113 | RGD:6480464 | CTD | |
| G | Nedd4l | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
affects expression | ISO | 18 | 61,134,242 | 61,477,040 | RGD:6480464 | CTD | |
| G | Nedd4l | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 18 | 61,134,242 | 61,477,040 | RGD:6480464 | CTD | |
| G | Nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions | ISO | 6 | 75,729,302 | 75,732,475 | RGD:6480464 | CTD | |
| G | Nol3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
affects expression | ISO | 19 | 35,094,345 | 35,096,012 | RGD:6480464 | CTD | |
| G | Nos2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 10 | 65,036,884 | 65,072,453 | RGD:6480464 | CTD | |
| G | Nov | nephroblastoma overexpressed |
|
decreases expression | ISO | 7 | 91,162,676 | 91,169,696 | RGD:6480464 | CTD | |
| G | Npy5r | neuropeptide Y receptor Y5 |
|
multiple interactions | ISO | 16 | 24,765,175 | 24,773,132 | RGD:6480464 | CTD | |
| G | Npy5r | neuropeptide Y receptor Y5 |
|
increases expression | ISO | 16 | 24,765,175 | 24,773,132 | RGD:6480464 | CTD | |
| G | Nqo1 | NAD(P)H dehydrogenase, quinone 1 |
|
decreases expression | ISO | 19 | 37,251,147 | 37,266,040 | RGD:6480464 | CTD | |
| G | Nr1h2 | nuclear receptor subfamily 1, group H, member 2 |
|
decreases expression | ISO | 1 | 95,027,197 | 95,032,516 | RGD:6480464 | CTD | |
| G | Nr1h4 | nuclear receptor subfamily 1, group H, member 4 |
|
decreases expression | ISO | 7 | 26,189,759 | 26,307,061 | RGD:6480464 | CTD | |
| G | Nr1i2 | nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions | ISO | 11 | 64,239,918 | 64,276,702 | RGD:6480464 | CTD | |
| G | Nr1i2 | nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions | ISO | 11 | 64,239,918 | 64,276,702 | RGD:6480464 | CTD | |
| G | Nr1i2 | nuclear receptor subfamily 1, group I, member 2 |
|
increases activity | ISO | 11 | 64,239,918 | 64,276,702 | RGD:6480464 | CTD | |
| G | Nr1i3 | nuclear receptor subfamily 1, group I, member 3 |
|
increases activity | ISO | 13 | 87,104,241 | 87,108,563 | RGD:6480464 | CTD | |
| G | Nr1i3 | nuclear receptor subfamily 1, group I, member 3 |
|
increases activity | ISO | 13 | 87,104,241 | 87,108,563 | RGD:6480464 | CTD | |
| G | Nr1i3 | nuclear receptor subfamily 1, group I, member 3 |
|
increases expression | ISO | 13 | 87,104,241 | 87,108,563 | RGD:6480464 | CTD | |
| G | Nr4a1 | nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression | ISO | 7 | 140,012,807 | 140,020,590 | RGD:6480464 | CTD | |
| G | Nr4a1 | nuclear receptor subfamily 4, group A, member 1 |
|
affects expression | ISO | 7 | 140,012,807 | 140,020,590 | RGD:6480464 | CTD | |
| G | Nr4a1 | nuclear receptor subfamily 4, group A, member 1 |
|
increases expression | ISO | 7 | 140,012,807 | 140,020,590 | RGD:6480464 | CTD | |
| G | Nr4a1 | nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression | EXP | 7 | 140,012,807 | 140,020,590 | RGD:6480464 | CTD | |
| G | Nr4a2 | nuclear receptor subfamily 4, group A, member 2 |
|
increases expression | ISO | 3 | 38,866,205 | 38,871,678 | RGD:6480464 | CTD | |
| G | Nr5a1 | nuclear receptor subfamily 5, group A, member 1 |
|
increases activity | ISO | 3 | 18,498,913 | 18,519,738 | RGD:6480464 | CTD | |
| G | Nr5a1 | nuclear receptor subfamily 5, group A, member 1 |
|
multiple interactions | ISO | 3 | 18,498,913 | 18,519,738 | RGD:6480464 | CTD | |
| G | Nr5a2 | nuclear receptor subfamily 5, group A, member 2 |
|
increases expression | ISO | 13 | 49,931,592 | 50,048,756 | RGD:6480464 | CTD | |
| G | Nr5a2 | nuclear receptor subfamily 5, group A, member 2 |
|
decreases expression | ISO | 13 | 49,931,592 | 50,048,756 | RGD:6480464 | CTD | |
| G | Nrep | neuronal regeneration related protein |
|
affects expression | ISO | 18 | 25,842,127 | 25,868,219 | RGD:6480464 | CTD | |
| G | Nrf1 | nuclear respiratory factor 1 |
|
increases expression | ISO | 4 | 56,949,553 | 57,048,149 | RGD:6480464 | CTD | |
| G | Nrf1 | nuclear respiratory factor 1 |
|
multiple interactions | ISO | 4 | 56,949,553 | 57,048,149 | RGD:6480464 | CTD | |
| G | Nrf1 | nuclear respiratory factor 1 |
|
multiple interactions | EXP | 4 | 56,949,553 | 57,048,149 | RGD:6480464 | CTD | |
| G | Nrg1 | neuregulin 1 |
|
decreases expression | EXP | 16 | 63,937,796 | 64,126,183 | RGD:6480464 | CTD | |
| G | Nrip1 | nuclear receptor interacting protein 1 |
|
affects expression | ISO | 11 | 15,066,443 | 15,150,137 | RGD:6480464 | CTD | |
| G | Nrip1 | nuclear receptor interacting protein 1 |
|
affects expression | ISO | 11 | 15,066,443 | 15,150,137 | RGD:6480464 | CTD | |
| G | Nrip1 | nuclear receptor interacting protein 1 |
|
increases expression | ISO | 11 | 15,066,443 | 15,150,137 | RGD:6480464 | CTD | |
| G | Nrip1 | nuclear receptor interacting protein 1 |
|
multiple interactions | EXP | 11 | 15,066,443 | 15,150,137 | RGD:6480464 | CTD | |
| G | Nrp1 | neuropilin 1 |
|
increases expression | ISO | 19 | 58,332,004 | 58,487,686 | RGD:6480464 | CTD | |
| G | Nrtn | neurturin | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Ns5atp9 | NS5A (hepatitis C virus) transactivated protein 9 |
|
increases expression | ISO | 8 | 70,159,283 | 70,172,116 | RGD:6480464 | CTD | |
| G | Nt5c2 | 5'-nucleotidase, cytosolic II |
|
multiple interactions | ISO | 1 | 252,204,106 | 252,329,479 | RGD:6480464 | CTD | |
| G | Nt5c2 | 5'-nucleotidase, cytosolic II |
|
increases expression | ISO | 1 | 252,204,106 | 252,329,479 | RGD:6480464 | CTD | |
| G | Ntf3 | neurotrophin 3 |
|
increases expression | EXP | 4 | 162,435,781 | 162,506,961 | RGD:6480464 | CTD | |
| G | Ntf3 | neurotrophin 3 |
|
multiple interactions | EXP | 4 | 162,435,781 | 162,506,961 | RGD:6480464 | CTD | |
| G | Nthl1 | nth (endonuclease III)-like 1 (E.coli) |
|
affects expression | ISO | 10 | 13,883,284 | 13,889,790 | RGD:6480464 | CTD | |
| G | Ntn4 | netrin 4 |
|
increases expression | ISO | 7 | 30,717,988 | 30,832,378 | RGD:6480464 | CTD | |
| G | Nts | neurotensin |
|
increases expression | EXP | 7 | 40,474,654 | 40,484,058 | RGD:6480464 | CTD | |
| G | Nudt2 | nudix (nucleoside diphosphate linked moiety X)-type motif 2 |
|
decreases expression | ISO | 5 | 58,887,126 | 58,901,965 | RGD:6480464 | CTD | |
| G | Nudt6 | nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
|
multiple interactions | ISO | 2 | 123,947,307 | 123,962,639 | RGD:6480464 | CTD | |
| G | Nuf2 | NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression | ISO | 13 | 85,286,634 | 85,315,366 | RGD:6480464 | CTD | |
| G | Nuf2 | NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression | ISO | 13 | 85,286,634 | 85,315,366 | RGD:6480464 | CTD | |
| G | Nup133 | nucleoporin 133 |
|
multiple interactions | ISO | 19 | 54,089,391 | 54,139,882 | RGD:6480464 | CTD | |
| G | Nup133 | nucleoporin 133 |
|
decreases expression | ISO | 19 | 54,089,391 | 54,139,882 | RGD:6480464 | CTD | |
| G | Nus1 | nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae) |
|
increases expression | ISO | 20 | 31,143,886 | 31,170,668 | RGD:6480464 | CTD | |
| G | Nusap1 | nucleolar and spindle associated protein 1 |
|
increases expression | ISO | 3 | 106,134,200 | 106,165,155 | RGD:6480464 | CTD | |
| G | Nxf1 | nuclear RNA export factor 1 |
|
affects expression | ISO | 1 | 211,428,605 | 211,441,798 | RGD:6480464 | CTD | |
| G | Oas2 | 2'-5' oligoadenylate synthetase 2 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Oas2 | 2'-5' oligoadenylate synthetase 2 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Oasl | 2'-5'-oligoadenylate synthetase-like |
|
multiple interactions | ISO | 12 | 42,956,466 | 42,969,826 | RGD:6480464 | CTD | |
| G | Oasl | 2'-5'-oligoadenylate synthetase-like |
|
increases expression | ISO | 12 | 42,956,466 | 42,969,826 | RGD:6480464 | CTD | |
| G | Padi1 | peptidyl arginine deiminase, type I |
|
increases expression | ISO | 5 | 159,671,725 | 159,704,188 | RGD:6480464 | CTD | |
| G | Pafah1b1 | platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
affects expression | ISO | 10 | 61,955,348 | 62,037,871 | RGD:6480464 | CTD | |
| G | Pax5 | paired box 5 |
|
multiple interactions | ISO | 5 | 61,016,708 | 61,131,315 | RGD:6480464 | CTD | |
| G | Pbld2 | phenazine biosynthesis-like protein domain containing 2 |
|
decreases expression | ISO | 20 | 25,379,865 | 25,410,260 | RGD:6480464 | CTD | |
| G | Pcna | proliferating cell nuclear antigen |
|
increases expression | ISO | 3 | 120,008,715 | 120,012,589 | RGD:6480464 | CTD | |
| G | Pdcd4 | programmed cell death 4 |
|
increases expression | ISO | 1 | 260,183,648 | 260,202,032 | RGD:6480464 | CTD | |
| G | Pde3b | phosphodiesterase 3B, cGMP-inhibited |
|
increases expression | ISO | 1 | 172,409,282 | 172,577,108 | RGD:6480464 | CTD | |
| G | Pde4b | phosphodiesterase 4B, cAMP specific |
|
affects expression | ISO | 5 | 123,158,156 | 123,533,877 | RGD:6480464 | CTD | |
| G | Pde4c | phosphodiesterase 4C, cAMP-specific |
|
decreases expression | ISO | 16 | 19,197,277 | 19,215,627 | RGD:6480464 | CTD | |
| G | Pde4d | phosphodiesterase 4D, cAMP-specific |
|
decreases methylation | EXP | 2 | 40,196,097 | 41,311,012 | RGD:6480464 | CTD | |
| G | Pde4d | phosphodiesterase 4D, cAMP-specific |
|
increases expression | EXP | 2 | 40,196,097 | 41,311,012 | RGD:6480464 | CTD | |
| G | Pde5a | phosphodiesterase 5A, cGMP-specific |
|
decreases expression | ISO | 2 | 219,410,394 | 219,550,910 | RGD:6480464 | CTD | |
| G | Pdgfa | platelet-derived growth factor alpha polypeptide |
|
multiple interactions | ISO | 12 | 16,151,045 | 16,172,412 | RGD:6480464 | CTD | |
| G | Pdgfa | platelet-derived growth factor alpha polypeptide |
|
increases expression | ISO | 12 | 16,151,045 | 16,172,412 | RGD:6480464 | CTD | |
| G | Pdgfa | platelet-derived growth factor alpha polypeptide |
|
multiple interactions | ISO | 12 | 16,151,045 | 16,172,412 | RGD:6480464 | CTD | |
| G | Pdgfb | platelet-derived growth factor beta polypeptide |
|
multiple interactions | ISO | 7 | 118,244,385 | 118,262,021 | RGD:6480464 | CTD | |
| G | Pdgfb | platelet-derived growth factor beta polypeptide |
|
multiple interactions | ISO | 7 | 118,244,385 | 118,262,021 | RGD:6480464 | CTD | |
| G | Pdgfra | platelet derived growth factor receptor, alpha polypeptide |
|
affects expression | ISO | 14 | 35,369,422 | 35,418,126 | RGD:6480464 | CTD | |
| G | Pdk4 | pyruvate dehydrogenase kinase, isozyme 4 |
|
decreases expression | ISO | 4 | 30,235,296 | 30,245,298 | RGD:6480464 | CTD | |
| G | Pdk4 | pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression | ISO | 4 | 30,235,296 | 30,245,298 | RGD:6480464 | CTD | |
| G | Pdk4 | pyruvate dehydrogenase kinase, isozyme 4 |
|
affects expression | ISO | 4 | 30,235,296 | 30,245,298 | RGD:6480464 | CTD | |
| G | Pdlim3 | PDZ and LIM domain 3 |
|
affects expression | ISO | 16 | 49,637,068 | 49,668,802 | RGD:6480464 | CTD | |
| G | Pdlim5 | PDZ and LIM domain 5 |
|
multiple interactions | ISO | 2 | 240,177,301 | 240,304,192 | RGD:6480464 | CTD | |
| G | Pdlim5 | PDZ and LIM domain 5 |
|
increases expression | ISO | 2 | 240,177,301 | 240,304,192 | RGD:6480464 | CTD | |
| G | Pdpk1 | 3-phosphoinositide dependent protein kinase-1 |
|
multiple interactions | ISO | 10 | 13,329,708 | 13,394,080 | RGD:6480464 | CTD | |
| G | Pds5b | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
|
multiple interactions | ISO | 12 | 4,038,430 | 4,128,352 | RGD:6480464 | CTD | |
| G | Pds5b | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
|
increases expression | ISO | 12 | 4,038,430 | 4,128,352 | RGD:6480464 | CTD | |
| G | Pdzd2 | PDZ domain containing 2 |
|
multiple interactions | ISO | 2 | 61,828,127 | 61,953,671 | RGD:6480464 | CTD | |
| G | Pdzk1 | PDZ domain containing 1 |
|
increases expression | ISO | 2 | 191,643,593 | 191,675,995 | RGD:6480464 | CTD | |
| G | Pdzk1 | PDZ domain containing 1 |
|
affects expression | ISO | 2 | 191,643,593 | 191,675,995 | RGD:6480464 | CTD | |
| G | Pdzk1 | PDZ domain containing 1 |
|
multiple interactions | ISO | 2 | 191,643,593 | 191,675,995 | RGD:6480464 | CTD | |
| G | Pdzk1 | PDZ domain containing 1 |
|
increases expression | ISO | 2 | 191,643,593 | 191,675,995 | RGD:6480464 | CTD | |
| G | Peli1 | pellino E3 ubiquitin protein ligase 1 |
|
multiple interactions | ISO | 14 | 101,870,272 | 101,924,228 | RGD:6480464 | CTD | |
| G | Peli1 | pellino E3 ubiquitin protein ligase 1 |
|
increases expression | ISO | 14 | 101,870,272 | 101,924,228 | RGD:6480464 | CTD | |
| G | Peli3 | pellino E3 ubiquitin protein ligase family member 3 |
|
increases expression | ISO | 1 | 207,548,086 | 207,558,715 | RGD:6480464 | CTD | |
| G | Pelo | pelota homolog (Drosophila) |
|
increases expression | ISO | 2 | 45,900,723 | 45,902,491 | RGD:6480464 | CTD | |
| G | Penk | proenkephalin |
|
increases expression | EXP | 5 | 17,509,323 | 17,514,265 | RGD:6480464 | CTD | |
| G | Penk | proenkephalin |
|
decreases expression | ISO | 5 | 17,509,323 | 17,514,265 | RGD:6480464 | CTD | |
| G | Penk | proenkephalin |
|
increases expression | EXP | 5 | 17,509,323 | 17,514,265 | RGD:6480464 | CTD | |
| G | Penk | proenkephalin |
|
multiple interactions | EXP | 5 | 17,509,323 | 17,514,265 | RGD:6480464 | CTD | |
| G | Pepd | peptidase D |
|
increases expression | ISO | 1 | 87,421,576 | 87,547,908 | RGD:6480464 | CTD | |
| G | Per1 | period circadian clock 1 |
|
increases expression | EXP | 10 | 55,859,851 | 55,868,747 | RGD:6480464 | CTD | |
| G | Per1 | period circadian clock 1 |
|
increases expression | ISO | 10 | 55,859,851 | 55,868,747 | RGD:6480464 | CTD | |
| G | Per1 | period circadian clock 1 |
|
multiple interactions | EXP | 10 | 55,859,851 | 55,868,747 | RGD:6480464 | CTD | |
| G | Pfas | phosphoribosylformylglycinamidine synthase |
|
multiple interactions | ISO | 10 | 55,745,617 | 55,761,944 | RGD:6480464 | CTD | |
| G | Pfkfb1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
|
decreases expression | ISO | X | 39,838,471 | 39,886,071 | RGD:6480464 | CTD | |
| G | Pfkfb3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
decreases expression | ISO | 17 | 78,241,182 | 78,268,272 | RGD:6480464 | CTD | |
| G | Pfkfb4 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
|
decreases expression | ISO | 8 | 114,012,543 | 114,050,534 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
decreases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | EXP | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | EXP | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pik3r1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression | EXP | 2 | 32,602,673 | 32,675,350 | RGD:6480464 | CTD | |
| G | Pim1 | pim-1 oncogene |
|
affects expression | ISO | 20 | 7,817,403 | 7,821,800 | RGD:6480464 | CTD | |
| G | Pip5k1a | phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha |
|
multiple interactions | ISO | 2 | 189,962,527 | 190,005,684 | RGD:6480464 | CTD | |
| G | Pip5k1a | phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha |
|
increases expression | ISO | 2 | 189,962,527 | 190,005,684 | RGD:6480464 | CTD | |
| G | Plat | plasminogen activator, tissue |
|
multiple interactions | ISO | 16 | 73,711,323 | 73,736,328 | RGD:6480464 | CTD | |
| G | Plat | plasminogen activator, tissue |
|
increases secretion | ISO | 16 | 73,711,323 | 73,736,328 | RGD:6480464 | CTD | |
| G | Plk1 | polo-like kinase 1 |
|
multiple interactions | ISO | 1 | 181,002,811 | 181,012,741 | RGD:6480464 | CTD | |
| G | Plk2 | polo-like kinase 2 |
|
decreases expression | ISO | 2 | 41,800,745 | 41,806,503 | RGD:6480464 | CTD | |
| G | Plk2 | polo-like kinase 2 |
|
affects expression | ISO | 2 | 41,800,745 | 41,806,503 | RGD:6480464 | CTD | |
| G | Plk2 | polo-like kinase 2 |
|
affects expression | ISO | 2 | 41,800,745 | 41,806,503 | RGD:6480464 | CTD | |
| G | Plk3 | polo-like kinase 3 |
|
multiple interactions | ISO | 5 | 137,443,540 | 137,448,715 | RGD:6480464 | CTD | |
| G | Plk4 | polo-like kinase 4 |
|
increases expression | ISO | 2 | 127,760,508 | 127,779,640 | RGD:6480464 | CTD | |
| G | Plk4 | polo-like kinase 4 |
|
affects expression | ISO | 2 | 127,760,508 | 127,779,640 | RGD:6480464 | CTD | |
| G | Plod1 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
|
increases expression | ISO | 5 | 164,987,252 | 165,012,581 | RGD:6480464 | CTD | |
| G | Plod2 | procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression | ISO | 8 | 97,525,279 | 97,623,152 | RGD:6480464 | CTD | |
| G | Plod2 | procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
affects expression | ISO | 8 | 97,525,279 | 97,623,152 | RGD:6480464 | CTD | |
| G | Plscr1 | phospholipid scramblase 1 |
|
multiple interactions | ISO | 8 | 97,206,388 | 97,226,725 | RGD:6480464 | CTD | |
| G | Plscr1 | phospholipid scramblase 1 |
|
increases expression | ISO | 8 | 97,206,388 | 97,226,725 | RGD:6480464 | CTD | |
| G | Pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression | ISO | 18 | 62,914,845 | 62,918,832 | RGD:6480464 | CTD | |
| G | Pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 |
|
affects expression | ISO | 18 | 62,914,845 | 62,918,832 | RGD:6480464 | CTD | |
| G | Pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression | ISO | 18 | 62,914,845 | 62,918,832 | RGD:6480464 | CTD | |
| G | Pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions | ISO | 18 | 62,914,845 | 62,918,832 | RGD:6480464 | CTD | |
| G | Pmepa1 | prostate transmembrane protein, androgen induced 1 |
|
decreases expression | ISO | 3 | 164,094,654 | 164,140,142 | RGD:6480464 | CTD | |
| G | Pmp22 | peripheral myelin protein 22 |
|
multiple interactions | ISO | 10 | 49,305,835 | 49,335,864 | RGD:6480464 | CTD | |
| G | Pmp22 | peripheral myelin protein 22 |
|
decreases expression | ISO | 10 | 49,305,835 | 49,335,864 | RGD:6480464 | CTD | |
| G | Pnoc | prepronociceptin |
|
multiple interactions | EXP | 15 | 44,822,635 | 44,835,637 | RGD:6480464 | CTD | |
| G | Pnp | purine nucleoside phosphorylase |
|
increases expression | ISO | 15 | 26,929,784 | 26,937,434 | RGD:6480464 | CTD | |
| G | Pnp | purine nucleoside phosphorylase |
|
affects expression | ISO | 15 | 26,929,784 | 26,937,434 | RGD:6480464 | CTD | |
| G | Pnpla3 | patatin-like phospholipase domain containing 3 |
|
decreases expression | ISO | 7 | 122,152,092 | 122,171,994 | RGD:6480464 | CTD | |
| G | Poc5 | POC5 centriolar protein homolog (Chlamydomonas) |
|
increases expression | ISO | 2 | 26,848,282 | 26,877,049 | RGD:6480464 | CTD | |
| G | Pold4 | polymerase (DNA-directed), delta 4, accessory subunit |
|
decreases expression | ISO | 1 | 206,815,462 | 206,817,131 | RGD:6480464 | CTD | |
| G | Polr1a | polymerase (RNA) I polypeptide A |
|
affects expression | ISO | 4 | 105,187,426 | 105,251,385 | RGD:6480464 | CTD | |
| G | Polr2b | polymerase (RNA) II (DNA directed) polypeptide B |
|
increases expression | ISO | 14 | 33,069,966 | 33,107,615 | RGD:6480464 | CTD | |
| G | Polr2j | polymerase (RNA) II (DNA directed) polypeptide J |
|
multiple interactions | ISO | 12 | 21,658,406 | 21,663,958 | RGD:6480464 | CTD | |
| G | Pom121 | POM121 transmembrane nucleoporin |
|
affects expression | ISO | 12 | 22,431,380 | 22,448,734 | RGD:6480464 | CTD | |
| G | Pon1 | paraoxonase 1 |
|
decreases expression | ISO | 4 | 29,936,314 | 29,964,821 | RGD:6480464 | CTD | |
| G | Pou1f1 | POU class 1 homeobox 1 |
|
increases expression | ISO | 11 | 2,959,383 | 2,980,545 | RGD:6480464 | CTD | |
| G | Pou5f1 | POU class 5 homeobox 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Pou5f1 | POU class 5 homeobox 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Pou5f1 | POU class 5 homeobox 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Ppap2b | phosphatidic acid phosphatase type 2B |
|
multiple interactions | ISO | 5 | 126,121,416 | 126,197,099 | RGD:6480464 | CTD | |
| G | Ppap2b | phosphatidic acid phosphatase type 2B |
|
decreases expression | ISO | 5 | 126,121,416 | 126,197,099 | RGD:6480464 | CTD | |
| G | Ppap2c | phosphatidic acid phosphatase type 2c |
|
decreases expression | ISO | 7 | 11,694,272 | 11,702,348 | RGD:6480464 | CTD | |
| G | Ppapdc1b | phosphatidic acid phosphatase type 2 domain containing 1B |
|
increases expression | ISO | 16 | 70,724,412 | 70,728,550 | RGD:6480464 | CTD | |
| G | Pparg | peroxisome proliferator-activated receptor gamma |
|
multiple interactions | ISO | 4 | 151,492,220 | 151,617,331 | RGD:6480464 | CTD | |
| G | Pparg | peroxisome proliferator-activated receptor gamma |
|
increases expression | ISO | 4 | 151,492,220 | 151,617,331 | RGD:6480464 | CTD | |
| G | Pparg | peroxisome proliferator-activated receptor gamma |
|
decreases expression | ISO | 4 | 151,492,220 | 151,617,331 | RGD:6480464 | CTD | |
| G | Pparg | peroxisome proliferator-activated receptor gamma |
|
increases expression | ISO | 4 | 151,492,220 | 151,617,331 | RGD:6480464 | CTD | |
| G | Ppargc1a | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions | ISO | 14 | 64,278,115 | 64,370,912 | RGD:6480464 | CTD | |
| G | Ppp1r15a | protein phosphatase 1, regulatory subunit 15A |
|
increases expression | ISO | 1 | 95,994,023 | 95,997,080 | RGD:6480464 | CTD | |
| G | Ppp4r4 | protein phosphatase 4, regulatory subunit 4 |
|
increases expression | ISO | 6 | 127,800,835 | 127,884,950 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
multiple interactions | ISO | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
increases secretion | ISO | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
increases expression | EXP | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
increases expression | EXP | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
increases secretion | EXP | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
increases secretion | EXP | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
multiple interactions | EXP | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
increases expression | EXP | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prss23 | protease, serine, 23 |
|
increases expression | ISO | 1 | 146,081,552 | 146,089,928 | RGD:6480464 | CTD | |
| G | Prss23 | protease, serine, 23 |
|
multiple interactions | ISO | 1 | 146,081,552 | 146,089,928 | RGD:6480464 | CTD | |
| G | Psat1 | phosphoserine aminotransferase 1 |
|
increases expression | ISO | 1 | 219,268,419 | 219,290,273 | RGD:6480464 | CTD | |
| G | Psca | prostate stem cell antigen |
|
decreases expression | ISO | 7 | 112,823,862 | 112,835,190 | RGD:6480464 | CTD | |
| G | Psca | prostate stem cell antigen |
|
multiple interactions | ISO | 7 | 112,823,862 | 112,835,190 | RGD:6480464 | CTD | |
| G | Psmb9 | proteasome (prosome, macropain) subunit, beta type, 9 |
|
increases expression | ISO | 20 | 4,801,187 | 4,806,608 | RGD:6480464 | CTD | |
| G | Psmc5 | proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
affects expression | ISO | 10 | 95,650,987 | 95,656,921 | RGD:6480464 | CTD | |
| G | Psmd12 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 |
|
increases expression | ISO | 10 | 96,881,373 | 96,907,258 | RGD:6480464 | CTD | |
| G | Psmd14 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
increases expression | ISO | 3 | 43,660,136 | 43,699,412 | RGD:6480464 | CTD | |
| G | Psmd14 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
affects expression | ISO | 3 | 43,660,136 | 43,699,412 | RGD:6480464 | CTD | |
| G | Psmd4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
affects expression | ISO | 2 | 189,933,161 | 189,942,421 | RGD:6480464 | CTD | |
| G | Psmd6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
increases expression | ISO | 15 | 12,650,570 | 12,660,487 | RGD:6480464 | CTD | |
| G | Psme4 | proteasome (prosome, macropain) activator subunit 4 |
|
increases expression | ISO | 14 | 111,892,871 | 111,997,184 | RGD:6480464 | CTD | |
| G | Pspc1 | paraspeckle component 1 |
|
affects expression | ISO | 15 | 35,718,357 | 35,779,139 | RGD:6480464 | CTD | |
| G | Ptafr | platelet-activating factor receptor |
|
affects expression | ISO | 5 | 152,565,687 | 152,587,342 | RGD:6480464 | CTD | |
| G | Ptch1 | patched 1 |
|
decreases expression | EXP | 17 | 7,088,234 | 7,142,459 | RGD:6480464 | CTD | |
| G | Pten | phosphatase and tensin homolog |
|
decreases expression | ISO | 1 | 236,771,027 | 236,837,261 | RGD:6480464 | CTD | |
| G | Pten | phosphatase and tensin homolog |
|
multiple interactions | ISO | 1 | 236,771,027 | 236,837,261 | RGD:6480464 | CTD | |
| G | Pten | phosphatase and tensin homolog |
|
increases expression | ISO | 1 | 236,771,027 | 236,837,261 | RGD:6480464 | CTD | |
| G | Pten | phosphatase and tensin homolog |
|
multiple interactions | ISO | 1 | 236,771,027 | 236,837,261 | RGD:6480464 | CTD | |
| G | Pten | phosphatase and tensin homolog |
|
increases expression | ISO | 1 | 236,771,027 | 236,837,261 | RGD:6480464 | CTD | |
| G | Pten | phosphatase and tensin homolog |
|
multiple interactions | ISO | 1 | 236,771,027 | 236,837,261 | RGD:6480464 | CTD | |
| G | Pten | phosphatase and tensin homolog |
|
multiple interactions | EXP | 1 | 236,771,027 | 236,837,261 | RGD:6480464 | CTD | |
| G | Pten | phosphatase and tensin homolog |
|
decreases expression | EXP | 1 | 236,771,027 | 236,837,261 | RGD:6480464 | CTD | |
| G | Ptger3 | prostaglandin E receptor 3 (subtype EP3) |
|
affects expression | ISO | 2 | 255,680,691 | 255,759,202 | RGD:6480464 | CTD | |
| G | Ptger3 | prostaglandin E receptor 3 (subtype EP3) |
|
increases expression | ISO | 2 | 255,680,691 | 255,759,202 | RGD:6480464 | CTD | |
| G | Ptger4 | prostaglandin E receptor 4 (subtype EP4) |
|
multiple interactions | ISO | 2 | 54,423,280 | 54,433,907 | RGD:6480464 | CTD | |
| G | Ptger4 | prostaglandin E receptor 4 (subtype EP4) |
|
increases expression | ISO | 2 | 54,423,280 | 54,433,907 | RGD:6480464 | CTD | |
| G | Ptges | prostaglandin E synthase |
|
multiple interactions | ISO | 3 | 9,946,194 | 9,957,538 | RGD:6480464 | CTD | |
| G | Ptges | prostaglandin E synthase |
|
increases expression | ISO | 3 | 9,946,194 | 9,957,538 | RGD:6480464 | CTD | |
| G | Ptgfr | prostaglandin F receptor | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
multiple interactions | EXP | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Ptk2 | protein tyrosine kinase 2 |
|
increases phosphorylation | ISO | 7 | 110,933,298 | 111,084,554 | RGD:6480464 | CTD | |
| G | Ptpro | protein tyrosine phosphatase, receptor type, O |
|
decreases expression | ISO | 4 | 174,376,396 | 174,586,694 | RGD:6480464 | CTD | |
| G | Rab30 | RAB30, member RAS oncogene family |
|
affects expression | ISO | 1 | 149,656,373 | 149,670,208 | RGD:6480464 | CTD | |
| G | Rab31 | RAB31, member RAS oncogene family |
|
increases expression | ISO | 9 | 104,408,546 | 104,543,084 | RGD:6480464 | CTD | |
| G | Rab32 | RAB32, member RAS oncogene family |
|
affects expression | ISO | 1 | 5,203,908 | 5,218,416 | RGD:6480464 | CTD | |
| G | Rad51 | RAD51 homolog (S. cerevisiae) |
|
increases expression | ISO | 3 | 105,625,265 | 105,650,392 | RGD:6480464 | CTD | |
| G | Rad51ap1 | RAD51 associated protein 1 |
|
increases expression | ISO | 4 | 163,308,788 | 163,321,854 | RGD:6480464 | CTD | |
| G | Ran | RAN, member RAS oncogene family |
|
affects expression | ISO | 12 | 28,736,786 | 28,739,921 | RGD:6480464 | CTD | |
| G | Rasgrp1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
increases expression | ISO | 3 | 103,371,879 | 103,433,010 | RGD:6480464 | CTD | |
| G | Rasl2-9 | RAS-like, family 2, locus 9 |
|
increases expression | ISO | 1 | 67,456,941 | 67,458,118 | RGD:6480464 | CTD | |
| G | Rbbp6 | retinoblastoma binding protein 6 |
|
multiple interactions | ISO | 1 | 181,818,248 | 181,849,942 | RGD:6480464 | CTD | |
| G | Rbbp8 | retinoblastoma binding protein 8 |
|
increases expression | ISO | 18 | 3,266,565 | 3,333,153 | RGD:6480464 | CTD | |
| G | Rbm14 | RNA binding motif protein 14 |
|
decreases expression | EXP | 1 | 207,410,484 | 207,421,760 | RGD:6480464 | CTD | |
| G | Rbmxrtl | RNA binding motif protein, X chromosome retrogene-like |
|
affects expression | ISO | 19 | 31,310,317 | 31,313,892 | RGD:6480464 | CTD | |
| G | Rdh7 | retinol dehydrogenase 7 |
|
decreases expression | ISO | 7 | 67,818,370 | 67,831,729 | RGD:6480464 | CTD | |
| G | Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 1 | 208,262,669 | 208,273,148 | RGD:6480464 | CTD | |
| G | Relb | v-rel reticuloendotheliosis viral oncogene homolog B | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | RGD1306148 | similar to KIAA0368 |
|
affects expression | ISO | 5 | 76,827,647 | 76,942,881 | RGD:6480464 | CTD | |
| G | Rnd1 | Rho family GTPase 1 |
|
increases expression | ISO | 7 | 137,418,519 | 137,425,590 | RGD:6480464 | CTD | |
| G | Rrm2 | ribonucleotide reductase M2 |
|
increases expression | ISO | 6 | 42,350,541 | 42,356,748 | RGD:6480464 | CTD | |
| G | RT1-CE7 | RT1 class I, locus CE7 |
|
increases expression | ISO | 20 | 3,410,094 | 3,413,041 | RGD:6480464 | CTD | |
| G | RT1-CE7 | RT1 class I, locus CE7 |
|
multiple interactions | ISO | 20 | 3,410,094 | 3,413,041 | RGD:6480464 | CTD | |
| G | RT1-M3-1 | RT1 class Ib, locus M3, gene 1 |
|
increases expression | ISO | 20 | 1,412,553 | 1,416,692 | RGD:6480464 | CTD | |
| G | RT1-M3-1 | RT1 class Ib, locus M3, gene 1 |
|
multiple interactions | ISO | 20 | 1,412,553 | 1,416,692 | RGD:6480464 | CTD | |
| G | RT1-M3-1 | RT1 class Ib, locus M3, gene 1 |
|
multiple interactions | ISO | 20 | 1,412,553 | 1,416,692 | RGD:6480464 | CTD | |
| G | RT1-M3-1 | RT1 class Ib, locus M3, gene 1 |
|
increases expression | ISO | 20 | 1,412,553 | 1,416,692 | RGD:6480464 | CTD | |
| G | RT1-M5 | RT1 class Ib, locus M5 |
|
increases expression | ISO | 20 | 1,638,276 | 1,640,540 | RGD:6480464 | CTD | |
| G | RT1-M5 | RT1 class Ib, locus M5 |
|
multiple interactions | ISO | 20 | 1,638,276 | 1,640,540 | RGD:6480464 | CTD | |
| G | Ryr2 | ryanodine receptor 2, cardiac |
|
decreases expression | EXP | 17 | 68,959,042 | 69,544,816 | RGD:6480464 | CTD | |
| G | S100g | S100 calcium binding protein G |
|
increases expression | EXP | X | 52,446,817 | 52,449,342 | RGD:6480464 | CTD | |
| G | Sac3d1 | SAC3 domain containing 1 |
|
increases expression | ISO | 1 | 208,889,495 | 208,891,944 | RGD:6480464 | CTD | |
| G | Sec16a | SEC16 homolog A (S. cerevisiae) |
|
multiple interactions | ISO | 3 | 4,583,882 | 4,613,980 | RGD:6480464 | CTD | |
| G | Sec16a | SEC16 homolog A (S. cerevisiae) |
|
decreases expression | ISO | 3 | 4,583,882 | 4,613,980 | RGD:6480464 | CTD | |
| G | Selenbp1 | selenium binding protein 1 |
|
decreases expression | ISO | 2 | 189,840,450 | 189,881,332 | RGD:6480464 | CTD | |
| G | Sesn2 | sestrin 2 |
|
increases expression | ISO | 5 | 152,639,951 | 152,655,828 | RGD:6480464 | CTD | |
| G | Sgk1 | serum/glucocorticoid regulated kinase 1 |
|
decreases expression | ISO | 1 | 23,501,257 | 23,506,651 | RGD:6480464 | CTD | |
| G | Slc12a2 | solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
decreases expression | ISO | 18 | 53,673,215 | 53,741,352 | RGD:6480464 | CTD | |
| G | Slc16a10 | solute carrier family 16, member 10 (aromatic amino acid transporter) |
|
decreases expression | ISO | 20 | 44,211,651 | 44,325,332 | RGD:6480464 | CTD | |
| G | Slc26a6 | solute carrier family 26, member 6 |
|
decreases expression | ISO | 8 | 113,925,291 | 113,935,357 | RGD:6480464 | CTD | |
| G | Slc2a2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases expression | EXP | 2 | 116,036,501 | 116,065,834 | RGD:6480464 | CTD | |
| G | Slc30a3 | solute carrier family 30 (zinc transporter), member 3 |
|
decreases expression | ISO | 6 | 25,257,765 | 25,264,794 | RGD:6480464 | CTD | |
| G | Slc30a3 | solute carrier family 30 (zinc transporter), member 3 |
|
multiple interactions | ISO | 6 | 25,257,765 | 25,264,794 | RGD:6480464 | CTD | |
| G | Slc40a1 | solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression | ISO | 9 | 44,977,430 | 44,995,358 | RGD:6480464 | CTD | |
| G | Slc6a3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions | EXP | 1 | 30,516,568 | 30,557,540 | RGD:6480464 | CTD | |
| G | Slc7a5 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
increases expression | ISO | 19 | 52,120,728 | 52,149,332 | RGD:6480464 | CTD | |
| G | Smg1 | smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) |
|
decreases expression | ISO | 1 | 176,347,187 | 176,442,991 | RGD:6480464 | CTD | |
| G | Snrpa1 | small nuclear ribonucleoprotein polypeptide A' |
|
affects expression | ISO | 1 | 120,490,921 | 120,503,974 | RGD:6480464 | CTD | |
| G | Spag4 | sperm associated antigen 4 |
|
multiple interactions | ISO | 3 | 146,472,609 | 146,476,953 | RGD:6480464 | CTD | |
| G | Spag4 | sperm associated antigen 4 |
|
increases expression | ISO | 3 | 146,472,609 | 146,476,953 | RGD:6480464 | CTD | |
| G | Spc25 | SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression | ISO | 3 | 51,361,185 | 51,374,357 | RGD:6480464 | CTD | |
| G | Spdl1 | spindle apparatus coiled-coil protein 1 |
|
increases expression | ISO | 10 | 19,684,827 | 19,709,881 | RGD:6480464 | CTD | |
| G | Sqrdl | sulfide quinone reductase-like (yeast) |
|
increases expression | ISO | 3 | 109,743,347 | 109,752,321 | RGD:6480464 | CTD | |
| G | St8sia4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
|
increases expression | ISO | 9 | 94,820,275 | 94,859,691 | RGD:6480464 | CTD | |
| G | St8sia4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
|
multiple interactions | ISO | 9 | 94,820,275 | 94,859,691 | RGD:6480464 | CTD | |
| G | Star | steroidogenic acute regulatory protein |
|
decreases expression | EXP | 16 | 70,642,580 | 70,647,203 | RGD:6480464 | CTD | |
| G | Stat3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression | ISO | 10 | 89,821,078 | 89,872,970 | RGD:6480464 | CTD | |
| G | Stc2 | stanniocalcin 2 |
|
increases expression | ISO | 10 | 16,514,603 | 16,524,369 | RGD:6480464 | CTD | |
| G | Stk39 | serine threonine kinase 39 |
|
increases expression | ISO | 3 | 50,249,626 | 50,517,085 | RGD:6480464 | CTD | |
| G | Stk39 | serine threonine kinase 39 |
|
multiple interactions | ISO | 3 | 50,249,626 | 50,517,085 | RGD:6480464 | CTD | |
| G | Stmn1 | stathmin 1 |
|
increases expression | ISO | 5 | 153,226,420 | 153,232,084 | RGD:6480464 | CTD | |
| G | Stub1 | STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 10 | 15,096,150 | 15,098,431 | RGD:6480464 | CTD | |
| G | Tacc1 | transforming, acidic coiled-coil containing protein 1 |
|
decreases expression | ISO | 16 | 71,241,785 | 71,304,959 | RGD:6480464 | CTD | |
| G | Tcf19 | transcription factor 19 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Tert | telomerase reverse transcriptase |
|
increases activity | ISO | 1 | 30,445,180 | 30,465,942 | RGD:6480464 | CTD | |
| G | Tert | telomerase reverse transcriptase |
|
increases expression | ISO | 1 | 30,445,180 | 30,465,942 | RGD:6480464 | CTD | |
| G | Tfap2c | transcription factor AP-2 gamma |
|
affects expression | ISO | 3 | 163,459,283 | 163,467,166 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
increases expression | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
increases expression | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
multiple interactions | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
multiple interactions | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
multiple interactions | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
multiple interactions | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
increases expression | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
increases secretion | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff3 | trefoil factor 3, intestinal |
|
increases expression | ISO | 20 | 9,469,888 | 9,474,604 | RGD:6480464 | CTD | |
| G | Tfpi2 | tissue factor pathway inhibitor 2 |
|
increases expression | ISO | 4 | 28,807,080 | 28,811,502 | RGD:6480464 | CTD | |
| G | Tgfb1 | transforming growth factor, beta 1 |
|
affects expression | ISO | 1 | 80,894,705 | 80,911,020 | RGD:6480464 | CTD | |
| G | Tgfbi | transforming growth factor, beta induced |
|
multiple interactions | ISO | 17 | 13,904,882 | 13,935,110 | RGD:6480464 | CTD | |
| G | Tgfbi | transforming growth factor, beta induced |
|
decreases expression | ISO | 17 | 13,904,882 | 13,935,110 | RGD:6480464 | CTD | |
| G | Tgfbi | transforming growth factor, beta induced |
|
increases expression | ISO | 17 | 13,904,882 | 13,935,110 | RGD:6480464 | CTD | |
| G | Tgfbrap1 | transforming growth factor, beta receptor associated protein 1 |
|
affects expression | ISO | 9 | 42,251,501 | 42,301,886 | RGD:6480464 | CTD | |
| G | Tie1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
|
affects expression | ISO | 5 | 138,945,238 | 138,964,631 | RGD:6480464 | CTD | |
| G | Tk1 | thymidine kinase 1, soluble | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Tmprss3 | transmembrane protease, serine 3 |
|
increases expression | ISO | 20 | 9,545,077 | 9,564,261 | RGD:6480464 | CTD | |
| G | Top2a | topoisomerase (DNA) II alpha |
|
increases expression | ISO | 10 | 87,771,337 | 87,800,960 | RGD:6480464 | CTD | |
| G | Ttk | Ttk protein kinase |
|
increases expression | ISO | 8 | 88,906,665 | 88,944,613 | RGD:6480464 | CTD | |
| G | Tyms | thymidylate synthetase |
|
increases expression | ISO | 9 | 112,604,912 | 112,617,706 | RGD:6480464 | CTD | |
| G | Ugt1a8 | UDP glycosyltransferase 1 family, polypeptide A8 |
|
decreases activity | ISO | 9 | 87,017,029 | 87,098,362 | RGD:6480464 | CTD | |
| G | Ugt1a8 | UDP glycosyltransferase 1 family, polypeptide A8 |
|
increases glucuronidation | ISO | 9 | 87,017,029 | 87,098,362 | RGD:6480464 | CTD | |
| G | Uhrf1 | ubiquitin-like with PHD and ring finger domains 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Was | Wiskott-Aldrich syndrome |
|
increases expression | ISO | X | 26,436,292 | 26,444,997 | RGD:6480464 | CTD | |
| G | Wsb1 | WD repeat and SOCS box-containing 1 |
|
multiple interactions | ISO | 10 | 65,427,131 | 65,443,208 | RGD:6480464 | CTD | |
| G | Wsb1 | WD repeat and SOCS box-containing 1 |
|
increases expression | ISO | 10 | 65,427,131 | 65,443,208 | RGD:6480464 | CTD | |
| G | Wsb1 | WD repeat and SOCS box-containing 1 |
|
affects expression | ISO | 10 | 65,427,131 | 65,443,208 | RGD:6480464 | CTD | |
| G | Zfp366 | zinc finger protein 366 |
|
multiple interactions | ISO | 2 | 30,218,990 | 30,237,606 | RGD:6480464 | CTD | |
Term paths to the root




browse the term